Health News

Latest medical research findings, public health updates, and evidence-based health news from iMedic.

797 articles

Articles

GLP-1 Weight-Loss Drugs and Heart Risk

New evidence strengthens the case that GLP-1 weight-loss drugs may reduce heart attack and stroke risk in high-risk adults.
Azithromycin Fails to Improve Preschool Wheezing

New research shows the antibiotic azithromycin does not improve outcomes for preschool children with wheezing treated in the emergency room.
Tirzepatide for Sleep Apnea: Which Patients See

New research identifies which patients with obesity and obstructive sleep apnea benefit most from tirzepatide, the GLP-1/GIP agonist now FDA-approved for OSA.
How GLP-1 Drugs Like Ozempic Are Reshaping Sleep Apnea

GLP-1 receptor agonists like Ozempic may offer a new treatment path for obstructive sleep apnea by targeting weight loss and upper airway inflammation.
GLP-1 Drugs Like Ozempic Open New Treatment Path

GLP-1 receptor agonists such as semaglutide and tirzepatide are emerging as a viable treatment for obstructive sleep apnea by targeting obesity, the leading
Exercise Builds Strength In The Brain First, Not Just

New neuroscience research suggests strength gains from exercise are driven as much by persistent brain cell activity as by muscle adaptation itself.
Tiny Gut Particles May Drive Aging and Chronic Disease

New research suggests microscopic particles released from the gut may fuel inflammation and age-related chronic disease, while young-gut particles may reverse
Mitochondrial Dysfunction and Memory Loss

New research shows malfunctioning mitochondria may directly cause cognitive decline in neurodegenerative diseases — and restoring brain cell energy could
Menopause Hot Flashes Disrupt Sleep

More than a third of menopausal women lose sleep to nighttime hot flashes, according to new AASM survey data highlighting an underrecognized health burden.
Which Diet Patterns May Slow Biological Aging?

Emerging research suggests Mediterranean, MIND, and plant-forward diets may slow biological aging markers and extend healthspan in older adults.
How Sleep Patterns Influence Dementia Risk

Researchers are uncovering how disrupted sleep may accelerate dementia risk through impaired brain clearance of toxic proteins like amyloid-beta and tau.
Tiny Gut Particles Identified as Hidden Drivers

New research suggests microscopic particles released from the gut may actively fuel inflammation and chronic disease in aging, while particles from young
Weight Loss Maintenance: Randomized Trial Tests

A new Nature Medicine randomized trial examines strategies to prevent weight regain after initial loss, addressing one of obesity medicine's hardest problems.
GLP-1 Weight-Loss Drugs Linked to Lower Death

New JAMA Network Open research finds GLP-1 receptor agonists like semaglutide may improve survival and reduce recurrence in breast cancer patients with obesity
APOE2 Gene Variant Helps Neurons Repair DNA

New research reveals how the APOE2 gene variant helps brain cells repair DNA damage, explaining longevity and protection against Alzheimer's disease.
Gut-Derived Particles May Drive Inflammaging

New research suggests microscopic particles released from the gut may actively drive the low-grade inflammation behind aging and chronic disease.
WHO Moves to Expand Global Access to Fast-Acting Insulin

The World Health Organization advances steps to broaden access to fast-acting insulin analogues and semaglutide, two drugs central to diabetes and obesity care.
Sleep Sweet Spot: 6.4 to 7.8 Hours Linked

New research identifies a narrow nightly sleep window between roughly 6.4 and 7.8 hours that may best support healthy aging, cognition, and longevity.
Tai Chi and Baduanjin: How an 800-Year-Old Chinese

Clinical research shows traditional Chinese exercises like Tai Chi and Baduanjin can reduce blood pressure as effectively as brisk walking — without equipment.
Recharging Brain Mitochondria Reverses Memory Loss

New research suggests malfunctioning mitochondria directly drive cognitive decline, and restoring their function may reverse memory loss in neurodegenerative
Prenatal Antidepressant Exposure and Autism/ADHD Risk

New analysis suggests that increased autism and ADHD risk in children exposed to antidepressants in utero may largely disappear after adjusting for confounders.
Ancient Chinese Qigong Exercise Matches Brisk Walking

A clinical trial suggests Baduanjin, an 800-year-old Chinese qigong routine, lowers blood pressure as effectively as brisk walking in adults with stage 1
Tai Chi May Lower Blood Pressure

A clinical trial suggests the traditional Chinese exercise Tai Chi can reduce blood pressure in adults with prehypertension, potentially outperforming aerobic
Gut-Brain Axis: How Dysbiosis Links

New research highlights how gut microbiome imbalances may drive psychiatric symptoms and neurodegeneration in Alzheimer's and Parkinson's disease.
Daily Coffee Linked to Lower Dementia Risk

New long-term research suggests drinking 2-3 cups of coffee daily is associated with significantly lower dementia risk, especially in midlife.
Just 30 Minutes of Weekly High-Intensity Exercise Linked

New research suggests just 30 minutes of high-intensity exercise per week, split into short bursts, can meaningfully improve cardiovascular and metabolic
Antidepressants in Pregnancy

A new study finds that the apparent link between prenatal antidepressant exposure and autism or ADHD largely vanishes once underlying maternal depression is
Popular Workout Supplement May Reduce Heart Benefits

New research suggests a widely used pre-workout supplement may interfere with cardiovascular adaptations to exercise in women. Here's what the science shows.
Optimal Sleep Duration for Healthy Aging

New research suggests adults who sleep between 6.4 and 7.8 hours nightly show better markers of healthy aging and longevity than short or long sleepers.
Healthier Plant-Based Diet Linked to Lower Dementia Risk

A healthier plant-based diet rich in whole foods is associated with reduced dementia risk, according to research highlighted by Harvard Health.
Resetting Aged Blood Stem Cells

Researchers report that calming overactive lysosomes in aged blood stem cells can restore youthful function, opening a new front in anti-aging and immune health
Yo-Yo Dieting Reconsidered: New Analysis Challenges

A new comprehensive analysis questions whether weight cycling is truly more harmful than sustained obesity. Here's what the research actually shows.
Healthful Plant-Based Diet Linked to Lower Dementia

New analysis suggests a healthful plant-based diet rich in whole grains, vegetables, and legumes is associated with reduced dementia risk and slower cognitive
Ancient Chinese Exercise Baduanjin Lowers Blood Pressure

A clinical trial finds Baduanjin, an 800-year-old Chinese mind-body exercise, reduces blood pressure in adults with hypertension comparably to aerobic walking.
Daily Coffee Linked to Lower Dementia Risk

New long-term research suggests drinking two to three cups of coffee daily may significantly reduce dementia risk, particularly when consumed before age 75.
Sleep Duration Linked to Slower Biological Aging

Large-scale research published in Nature finds optimal sleep duration is associated with slower biological aging, with both too little and too much sleep
Integrated Behavioral Health Cuts Costs

New analysis finds integrated behavioral health models deliver cost-effective care for patients with depression, anxiety, and chronic pain — improving outcomes
Walking Tops Americans' Favorite Exercise List

New research reveals walking has overtaken gym workouts as America's favorite exercise, signaling a major shift toward accessible, low-impact fitness.
India's CDSCO Seeks Public Input on Drug Approval

India's drug regulator CDSCO opens public consultation on harmonizing drug approval pathways, aiming to align domestic and foreign manufacturers under unified
Peppermint Oil Lowers Blood Pressure

A University of Lancashire clinical trial finds daily peppermint oil capsules reduce blood pressure in patients with mildly elevated readings, suggesting a
Blood Pressure Drug Shows Promise for Reducing Arterial

New research suggests a common blood pressure medication may reduce arterial stiffening linked to obesity, offering hope for cardiovascular risk reduction.
Too Little or Too Much Sleep Accelerates Biological

New research links both short and long sleep duration to accelerated biological aging in the brain, heart, lungs, and immune system.
Resmetirom for MASH: How the First Approved Fatty Liver

Resmetirom (Rezdiffra), the first FDA-approved treatment for metabolic dysfunction-associated steatohepatitis, is changing hepatology practice as access expands
Blood Test Combining Biological Age and Genetic Risk

New research suggests a blood test pairing biological aging markers with genetic risk scores could identify people at elevated dementia risk well before
EMA Leverages Real-World Data Networks

The European Medicines Agency is scaling data-driven regulatory science through DARWIN EU and federated health data networks to improve drug safety and access.
FDA Blocks Publication of Studies Confirming COVID

The BMJ reports the FDA has suppressed publication of internal studies confirming COVID-19 and shingles vaccines are safe, raising serious questions about
Scientists Reverse Blood Stem Cell Aging

Researchers restored youthful function to aged blood stem cells by calming overactive lysosomes, opening new avenues for anti-aging and regenerative medicine.
Prenatal Chemical Exposure at Work Linked

New research suggests mothers occupationally exposed to toxic chemicals or high stress during pregnancy may have higher odds of having a child with autism
GLP-1 Drugs and Muscle Loss: New Research Finds Effects

New research from the Lifespan Research Institute suggests GLP-1 medications like semaglutide cause muscle loss similar to traditional weight loss, easing
8,500 Steps a Day Helps Dieters Keep Weight Off

New research suggests walking around 8,500 steps daily may help people who have lost weight successfully maintain their results long-term.
Human Pancreatic Islet Atlas Links Cell Composition

New research mapping human pancreatic islets reveals how the mix of alpha, beta, and delta cells shapes insulin secretion and individual diabetes risk.
Acupuncture and Microglial Modulation

Emerging research explores how acupuncture may target the neuro-immune axis and microglial activity to reduce chronic pain in juvenile idiopathic arthritis.
Circadian Rhythm Sleep Disorders

Circadian rhythm sleep disorders disrupt the body's internal clock. Learn the main types, who is at risk, and evidence-based treatments including light therapy
Personalized mRNA Vaccine Shows Promise

A personalized vaccine targeting glioblastoma elicited robust immune responses in early trials, offering new hope against one of the deadliest brain cancers.
Progeria: Rare Rapid-Aging Disease in Children Moves

Hutchinson-Gilford Progeria Syndrome causes children to age rapidly. New gene-editing and lonafarnib research is bringing scientists closer to a true cure.
Digitalis Glycosides Reduce Heart Failure Events

New late-breaking analyses presented at Heart Failure 2026 show digitalis glycosides reduce heart failure events, reviving interest in this historic cardiac
Largest Childhood Arthritis Study Uncovers

A landmark UCL-led study of children with juvenile idiopathic arthritis identifies new genetic pathways that could lead to better-targeted treatments.
Timely Pain Treatment Cuts Hospitalizations

New Northwestern research finds children with sickle cell disease who receive rapid pain treatment in the ER are less likely to be hospitalized.
Healthy Aging Reframed as Public Health Priority

Aging is increasingly seen as a modifiable public health target. New frameworks emphasize prevention, function, and equity across the lifespan.
RNA Therapy Shows Promise Slowing Harmful Heart

A novel RNA-based therapy slowed pathological left ventricular remodeling after acute myocardial infarction in an early clinical trial, offering new hope for
First Human Bird Flu Vaccine Enters US Clinical Trials

The first human avian influenza H5N1 vaccine has begun clinical trials in the US, marking a key milestone in pandemic preparedness against bird flu.
Pancreatic Cancer Treatment Advance

Researchers report a potential breakthrough in pancreatic cancer treatment, one of the most lethal cancers with historically poor survival outcomes.
Insulin-Requiring Diabetes Linked to Sharply Higher

A new analysis of 1.3 million people finds insulin-requiring diabetes carries the steepest dementia risk, reinforcing diabetes as a modifiable risk factor for
Walking 8,500 Steps Daily May Prevent Weight Regain

New international analysis suggests walking approximately 8,500 steps daily may help prevent weight regain after successful dieting, offering a simple
Ancient Tai Chi Practice Matches Brisk Walking

A landmark clinical trial finds tai chi may lower blood pressure as effectively as aerobic walking in adults with hypertension, offering a low-impact
Sleep Problems in Autistic Adults

Autistic adults face sleep disorders at much higher rates than neurotypical peers. New research explores causes — sensory sensitivity, melatonin differences
Oral Orforglipron Cuts Weight and Blood Sugar

New trial data show daily oral orforglipron meaningfully reduces body weight and improves glycemic control in seniors with type 2 diabetes.
FDA Moves to Fast-Track Psilocybin and Methylone Review

FDA signals accelerated review pathway for psilocybin and methylone as breakthrough therapies for treatment-resistant depression and PTSD.
FDA Delays Subcutaneous Leqembi Starting Dose Decision

FDA postpones decision on Biogen and Eisai's subcutaneous Leqembi (lecanemab) initiation dose, delaying at-home Alzheimer's treatment access for patients.
Low-Dose Digoxin Shows Renewed Promise in Heart Failure

A new randomized controlled trial in Nature Medicine reexamines low-dose digoxin in heart failure with reduced and mildly reduced ejection fraction.
Vitamin D Overdose: When Supplements Cross

Excessive vitamin D supplementation can cause hypercalcemia, kidney damage, and cardiovascular harm. Harvard Health experts warn against megadoses.
Personal Workout Music Can Extend Exercise Endurance

New research shows cyclists exercising with self-selected music lasted nearly 20% longer than in silence, revealing how personalized soundtracks reshape
Naked Mole Rat Longevity Gene Transferred

University of Rochester scientists transferred a longevity-linked gene from naked mole rats into mice, extending healthy lifespan and opening new aging research
Mayo Clinic Unveils New Treatment Pathways

Mayo Clinic introduces integrated treatment pathways for advanced heart failure, combining guideline-directed medical therapy, devices, and transplant
Erectile Dysfunction After Substance Use

How substance use disorders contribute to erectile dysfunction and which lifestyle, nutritional, and medical strategies support sexual recovery.
mRNA Cancer Vaccines: Promise of Personalized Treatment

mRNA cancer vaccines show transformative potential for treatment and prevention, but vaccine misinformation threatens clinical progress and patient access.
Tenecteplase Before Thrombectomy Extends Stroke

New trial data show intravenous tenecteplase given before endovascular thrombectomy may benefit stroke patients in the 4.5 to 24-hour window.
Exercise Snacks: Short Activity Bursts Boost Fitness

New BMJ research shows brief 'exercise snacks' — short bursts of vigorous activity — can meaningfully improve cardiorespiratory fitness in physically inactive
Fitness Social Media Use Linked to Better Exercise

New research finds fitness content on social media boosts exercise behavior by strengthening intrinsic motivation and exercise intention, especially among young
Type 1 Diabetes Blood Sugar Management

Insulin remains the cornerstone of type 1 diabetes care. A new review examines which supplements show evidence and which fall short.
Boston University Launches Center for Brain Recovery

Boston University's new Center for Brain Recovery aims to translate neuroscience research into therapies for stroke, Alzheimer's disease, and Parkinson's
Head Impacts Linked to Gut Microbiome Changes

New research finds non-concussive head impacts in football players are associated with measurable changes to the gut microbiome, suggesting a brain-gut axis
Why GLP-1 Weight-Loss Injections Are Not a Quick Fix

Experts warn GLP-1 weight-loss injections like semaglutide and tirzepatide require lifestyle changes, carry side effects, and are not a shortcut to lasting
Vaccine Breakthroughs Reshaping Medicine

Experts highlight a wave of vaccine breakthroughs reshaping global health, from mRNA cancer therapies to next-generation TB, malaria, and RSV shots.
Personalised mRNA Vaccines Enter Trial

Australian researchers launch a world-first trial of personalised mRNA vaccines targeting pediatric high-grade gliomas, including DIPG, using each child's
Hantavirus Cases in UK Travelers

A third British national has a suspected hantavirus infection, but WHO emphasizes this rodent-borne virus poses no pandemic threat. What travelers need to know.
Why Belly Fat Increases With Age

New research reveals how testosterone drives the redistribution of body fat into the dangerous abdominal region as we age, opening doors to targeted
Skin Aging Mechanisms: New Insights Reshape Clinical

Researchers map the molecular drivers of skin aging, opening doors to targeted dermatological treatments addressing cellular senescence, oxidative stress, and
FDA Issues Final Guidance on Pregnancy Safety Studies

FDA finalizes guidance for postapproval pregnancy safety studies, recommending stronger methodologies to protect pregnant patients prescribed drugs and
Scientists Identify Common Master Switch

Researchers report a shared molecular master switch driving multiple neurodegenerative diseases, opening a unified therapeutic pathway for Alzheimer's and
Brain Imaging Reveals Distinct Migraine Subtypes

Advanced MRI scans identify structural and functional differences between migraine subtypes, paving the way for targeted therapies beyond one-size-fits-all
Parkinson's and Alzheimer's Affect Distinct Brain

New neuroimaging research reveals Parkinson's and Alzheimer's diseases damage distinct brain networks, reshaping how cognitive decline is diagnosed and treated.
Yoga for Back Pain: How to Practice Safely

Evidence shows yoga can ease chronic low back pain when practiced safely. Learn which poses help, which to avoid, and how to start without injury.
Cash Prescription Program Linked to Sharp Drop

A JAMA Pediatrics study finds Michigan's Rx Kids cash prescription program significantly reduced infant maltreatment investigations in Flint families.
Trivalent mRNA Flu Vaccine Outperforms Standard Shots

An investigational mRNA-based trivalent influenza vaccine showed superior efficacy versus standard flu shots in adults aged 50 and older in the Fluent
Aluminum in Vaccines: BMJ Review Finds No Causal Link

A new BMJ systematic review concludes current evidence does not support causal links between aluminum vaccine adjuvants and chronic disease, reaffirming vaccine
Morning Checkpoint Inhibitor Doses Linked

New research suggests time-of-day matters for immunotherapy in hepatocellular carcinoma, with morning dosing associated with stronger immune responses and
Cognitive Behavioral Therapy Eases Menopausal Insomnia

CBT shows strong evidence for treating menopausal insomnia and vasomotor symptoms, offering a non-hormonal option for millions of women.
Seasonal Flu Vaccine Programs Boosted COVID-19 Rollout

New analysis shows countries with established seasonal flu vaccination programs achieved nearly double the COVID-19 vaccine coverage in the first year of
Fish Sleep in Four Distinct States Including Three

New research reveals fish experience four sleep states, including three with eye movements, reshaping understanding of REM sleep evolution across species.
Epilepsy and Autism in Children

New research in Developmental Medicine & Child Neurology examines why children with epilepsy face higher autism risk, identifying shared neurodevelopmental
Short Pembrolizumab Course Before Surgery Keeps

A UK-led trial shows nine weeks of pembrolizumab before surgery delivered durable remission in patients with mismatch repair deficient colorectal cancer.
Precision Psychiatry Arrives

Japan's regulatory approval of a near-infrared spectroscopy device for depression marks a turning point for biomarker-guided psychiatric care worldwide.
Irregular Sleep Schedule in Midlife Linked

New research links inconsistent bedtimes in middle age to substantially higher heart attack and stroke risk, independent of total sleep duration.
FDA Approves Dupixent for Chronic Hives in Children Aged

FDA expands Dupixent (dupilumab) approval to treat chronic spontaneous urticaria in children aged 2 to 11, offering a new biologic option for persistent hives.
Hidden Muscle Fat Linked to Heart Disease

Deep learning analysis of MRI scans shows intermuscular fat infiltration is strongly linked to high blood pressure, diabetes, and cardiovascular risk.
Insulin Resistance Before Stroke Linked

New Karolinska Institutet research finds insulin resistance before a stroke significantly impacts recovery outcomes in patients with type 2 diabetes.
Measles Resurgence: Why Cases Are Rising Globally

Measles cases surge worldwide as vaccination coverage drops below the 95% herd immunity threshold. Reviewed by iMedic's medical editorial team.
Travel as Anti-Aging Medicine

New research suggests positive travel experiences may slow biological aging by reducing entropy and supporting physical, mental, and social health.
Global Drug Access Gap: Why New Therapies Reach Patients

New analysis reveals stark disparities in how quickly innovative therapies reach patients in the US, EU, China, and Japan, with delays of several years for some
Best Exercise for Longevity: How Vigorous Intervals

New science reveals the optimal exercise mix for longevity combines vigorous intervals with zone 2 cardio and strength training to extend healthspan.
Higher Cardiorespiratory Fitness Linked

New research highlighted by Harvard Health shows higher fitness levels are associated with substantially lower risk of depression and dementia later in life.
FDA Accelerated Approval Faces Transparency Crisis

Research firm analysis reveals critical transparency gaps in FDA's accelerated approval pathway, prompting calls for stricter post-market evidence requirements.
How Sugar Powers Vision: Retinal Glucose Metabolism

NEI scientists discover that glucose metabolism in the retina directly controls epigenetic changes and gene activity in light-sensing photoreceptor cells.
Central Nervous System Drives Diabetic Pain

New research reveals the brain and spinal cord play a central role in painful diabetic neuropathy, opening doors to treatments that restore the body's natural
Weight Management May Slow Brain Aging Within Two Years

New 24-year University of Georgia research shows that being overweight accelerates cognitive decline, and weight management may protect brain health within two
COVID-19 Vaccine Breakthrough Infections

A nationwide survey of medical students examines COVID-19 vaccine breakthrough infections and adverse reactions, offering insights into vaccine performance in
Hip Replacement Outperforms Exercise Therapy Alone

A landmark yearlong randomized trial finds total hip arthroplasty delivers significantly better pain relief and function than exercise-only care in
GLP-1 Drugs and Mental Health

Emerging research suggests GLP-1 receptor agonists like semaglutide may reduce depression and anxiety risk through anti-inflammatory effects on the brain.
Benzodiazepine and Z-Hypnotic Use in Pregnancy

A large BMJ population-based cohort study examines whether benzodiazepine or Z-hypnotic use during pregnancy raises the risk of psychiatric disorders in
FDA Advisors Back AstraZeneca's Truqap Combo

FDA advisory committee supports AstraZeneca's Truqap (capivasertib) plus abiraterone for metastatic prostate cancer patients with PTEN loss, signaling a
Gut Health Foods: What the Science Says About Fiber

Evidence-based guide to foods that support gut microbiome health, including fiber-rich plants, fermented foods, and polyphenols backed by clinical research.
Axsome's Auvelity Wins FDA Nod

FDA approves Axsome Therapeutics' Auvelity (dextromethorphan-bupropion) for agitation in Alzheimer's dementia, offering a non-antipsychotic alternative for
Physician Burnout and Multimorbidity Care

A longitudinal study from Odisha reveals how physicians managed patients with multiple chronic conditions during COVID-19, exposing systemic gaps in primary
How Exercise Improves Sleep Quality in Older Adults

New research reveals how regular physical activity can significantly improve sleep quality in older adults with mild cognitive impairment, a key risk factor for
Stem Cell Therapy for Aging: What the Science Says About

Stem cell therapies for aging and longevity are gaining attention through medical tourism, but clinical evidence for bioregeneration remains limited and largely
Immunotherapy Trial Leaves Bowel Cancer Patients

A landmark immunotherapy trial shows patients with mismatch repair-deficient bowel cancer remain cancer-free up to three years after treatment with checkpoint
FDA Grants Expanded Access to Promising Pancreatic

FDA grants early access to an investigational pancreatic cancer drug, allowing patients with advanced disease to receive treatment before formal approval.
Mediterranean Diet: Cardiovascular

Harvard Health reviews the Mediterranean diet's evidence base for heart disease prevention, cognitive health, and longevity, highlighting key food groups and
Calories Burned in 30 Minutes

Harvard Health's updated chart shows how many calories you burn in 30 minutes of common activities — from gardening to brisk walking — and why small movement
Can GLP-1 Weight-Loss Drugs Protect

GLP-1 drugs like semaglutide are being studied for Alzheimer's prevention. UCSF researchers and the EVOKE trials examine neuroprotective effects beyond weight
Tubed vs Tubeless Insulin Pumps

A large French real-world analysis compares tubed and tubeless insulin pumps, offering new insights into glycemic control, adherence, and complications in type
Keto Crunch Smart Mix Recalled Over Undeclared Cashews

Second Nature Brands recalls 10-oz Keto Crunch Smart Mix over undeclared tree nuts and cherries, posing serious risk to people with food allergies.
FDA Approves Idvynso: Two-Drug Once-Daily Tablet

FDA approves Merck's Idvynso (doravirine/islatravir), a once-daily two-drug tablet for HIV-1, simplifying maintenance therapy for virologically suppressed
Maternal Fatty Acid Levels Linked to Childhood Asthma

Mothers with low levels of specific blood fatty acids during pregnancy have children with higher asthma risk, new research suggests.
GLP-1 Drugs and Body Positivity

GLP-1 drugs like Ozempic and Mounjaro are transforming weight loss medicine and challenging the body positivity movement.
New AHA/ACC Hypertension Guideline Prioritizes

Updated AHA/ACC high blood pressure guideline emphasizes lifestyle prevention, earlier pharmacotherapy, and lower targets to reduce heart attack, stroke, and
Brexpiprazole for Alzheimer's Agitation

Brexpiprazole (Rexulti) is the first FDA-approved drug for agitation in Alzheimer's dementia. Learn how it works, who qualifies, and key safety considerations.
Sleep Quality Linked to Heart Disease

The American Heart Association launches a comprehensive journal series examining how sleep duration, quality, and circadian rhythms shape cardiovascular health.
GLP-1 Drugs for Lifelong Use

Patients on GLP-1 drugs like Ozempic and Wegovy report rapid weight loss alongside cardiovascular and metabolic benefits, but long-term use raises questions.
NHLBI Advances Integrated Heart, Lung, Blood

The NIH's NHLBI is accelerating cross-disciplinary research linking cardiovascular, pulmonary, hematologic, and sleep disorders to address overlapping disease
How Much Exercise for Longevity?

New research clarifies the optimal exercise dose for longevity and heart health, showing benefits plateau around 300 minutes of moderate activity weekly.
GLP-1 Drugs Linked to Fewer Asthma Flare-Ups

New research suggests GLP-1 receptor agonists like semaglutide may reduce asthma exacerbations in adults with overweight or obesity, pointing to
DNA-Based Molecules Slash LDL Cholesterol by Nearly 50%

Novel DNA-based therapeutics targeting PCSK9 cut LDL cholesterol by nearly 50% in early studies, offering a promising non-statin pathway for high-risk patients.
FDA Moves to Restrict Mass Compounding

FDA proposes new restrictions on mass-compounded versions of semaglutide and tirzepatide, citing patient safety concerns as branded GLP-1 supply stabilizes.
PFAS in Baby Formula: FDA Review Finds Low Levels

FDA testing of 16 infant formula brands detected only trace PFAS levels. Experts explain what 'forever chemicals' findings mean for infant safety.
Vitamin C: New NIH Guidance on Immune Function

NIH Office of Dietary Supplements updates vitamin C guidance covering immune support, deficiency risks, smokers' needs, and evidence on supplementation.
Osteoarthritis Symptom Relief

Discover proven osteoarthritis treatments that ease joint pain and stiffness, plus emerging therapies reshaping the future of OA care.
FDA Approves Self-Administered Saphnelo

FDA approves AstraZeneca's Saphnelo (anifrolumab) for at-home self-administration in adults with moderate to severe systemic lupus erythematosus.
States Move to Drop GLP-1 Weight Loss Drugs

A growing number of US states are reconsidering Medicaid coverage of GLP-1 obesity drugs like Wegovy and Zepbound as budget pressures mount.
CDC's Uncertainty-Based Vaccine Messaging

New survey research suggests CDC's shift toward uncertainty-based vaccine communication may be eroding public trust and increasing belief in the debunked
Vegan Diet Outperforms Mediterranean

A randomized clinical trial shows a low-fat vegan diet reduces greenhouse gas emissions and improves metabolic markers more than the Mediterranean diet.
FDA Analysis Confirms US Infant Formula Safe

FDA testing finds reassuringly low levels of heavy metals, pesticides, and other contaminants in US infant formula, supporting the safety of the supply.
Dextromethorphan-Bupropion Approved

FDA clears Axsome's dextromethorphan-bupropion combination for Alzheimer's-related agitation, addressing a major unmet need with a non-antipsychotic mechanism.
Vegan Diet Clinical Trial Slashes Food-Related Emissions

A new randomized clinical trial finds a whole-food vegan diet substantially reduces dietary greenhouse gas emissions while lowering cholesterol and body weight.
IBD Immunosuppressants Show No Increased Heart Attack

New Medicare analysis finds no elevated risk of heart attacks or strokes in inflammatory bowel disease patients taking immunosuppressant therapies.
FDA Approves First Non-Antipsychotic Treatment

FDA expands approval of Auvelity (dextromethorphan-bupropion) for agitation associated with dementia, offering a non-antipsychotic option for patients.
mRNA Vaccine Clinical Trials Surge

A systematic analysis of ClinicalTrials.gov reveals the global mRNA vaccine pipeline has expanded far beyond COVID-19 into oncology, infectious disease, and
FDA Moves to Block Compounded GLP-1 Drugs

FDA proposes excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, ending compounding of these blockbuster GLP-1 weight loss drugs.
Pausing and Restarting GLP-1 Weight Loss Drugs

New research suggests stopping and restarting GLP-1 medications like semaglutide and tirzepatide for weight loss may reduce their long-term effectiveness.
Late-Start Menopause Hormone Therapy

New systematic review examines cardiovascular outcomes when menopause hormone therapy is started after age 60 or 10+ years post-menopause.
Biohaven Targets Muscle Preservation

While GLP-1 drugs dominate weight loss, Biohaven pursues muscle-preserving therapies to address sarcopenia risk in obesity treatment.
Aerobic Exercise Tops All Workouts for Knee Arthritis

A sweeping analysis of 217 trials concludes aerobic exercise like walking, cycling and swimming delivers the greatest pain relief for knee osteoarthritis.
GLP-1 Drugs May Lower Cardiovascular Risk

New analysis suggests GLP-1 receptor agonists may reduce cardiovascular events in patients with diabetes or obesity undergoing transcatheter aortic valve
FDA Grants Orphan Drug Designation

FDA awards Orphan Drug Designation to pegrizeprument, an investigational therapy aimed at preventing acute rejection in heart transplant recipients.
Deep Learning Model Transforms Handheld 3D Medical

Pusan National University researchers unveil a deep learning system that sharpens handheld 3D medical imaging, promising portable point-of-care diagnostics.
NIH Office of Dietary Supplements

The NIH Office of Dietary Supplements provides evidence-based fact sheets on vitamins, minerals, and botanicals — helping consumers separate science from
CDC Survey: Nearly Half of US Adults Sleep-Deprived

New CDC data reveal nearly half of American adults fail to get the recommended 7 hours of sleep, fueling rising rates of cardiovascular disease, diabetes and
Accelerated Theta Burst Stimulation Improves Social

A new non-invasive brain stimulation protocol called a-cTBS shows improvements in social communication for autistic children after just five days of treatment.
Tenecteplase Emerges as Faster Stroke Drug Alternative

New evidence supports tenecteplase as a single-bolus thrombolytic for ischemic stroke, offering faster administration and comparable outcomes to alteplase.
Single Dose of Creatine Boosts Brain Energy

New research shows a single high dose of creatine improves cognitive performance and replenishes brain energy stores during sleep deprivation, challenging
CRISPR Gene Therapy for Sickle Cell Disease

Nobel laureate Jennifer Doudna highlights how CRISPR gene therapy is transforming sickle cell disease treatment and what comes next for genetic medicine.
Dietary Supplements Boom: What the Evidence Says About

As the global supplement market surges, experts urge evidence-based use. Learn which supplements are backed by science and which carry hidden risks.
Anti-Aging Research Enters Human Clinical Trials

Longevity research moves from lab to humans as anti-aging compounds enter clinical trials. Experts like Andrea Maier discuss what this means for healthspan.
Prehabilitation: How Exercise

New review finds structured exercise and nutrition programs before surgery reduce complications and shorten hospital stays for patients undergoing major
Academic Research Drives FDA Approval

Academic-industry collaboration accelerates FDA approval of new therapies for rare genetic disorders, expanding treatment options for patients with limited
FDA Completes Largest-Ever Testing of Infant Formula

FDA releases results from the largest infant formula testing in U.S. history, examining chemical contaminants like heavy metals, BPA, and pesticides in products
Blood Test for Alzheimer's: How Plasma Biomarkers

FDA-cleared blood tests measuring p-tau217 and amyloid beta now enable earlier, less invasive Alzheimer's diagnosis, expanding access to disease-modifying
AI Sleep Foundation Model Predicts Disease Risk

A new multimodal AI foundation model analyzes sleep biosignals to predict risk for cardiovascular, metabolic, and neurological disease years in advance.
Boehringer's Survodutide Achieves 16.6% Weight Loss

Boehringer Ingelheim's dual GLP-1/glucagon receptor agonist survodutide showed 16.6% weight loss in phase 3 trials, intensifying competition in the obesity drug
Gut Microbiome and Aging: How Your Microbes Influence

Emerging research reveals how gut microbes influence biological aging. Scientists are uncovering microbiome-based strategies to support healthy longevity.
Bariatric Surgery Outperforms GLP-1 Drugs

Mayo Clinic research suggests bariatric surgery offers significantly greater long-term cardiovascular risk reduction than GLP-1 weight-loss medications in
FDA's New Drug Pricing Approach Adds Uncertainty

FDA's evolving consideration of drug pricing during approval reviews introduces new uncertainty for pharmaceutical companies and patient access.
Oral PCSK9 Inhibitor Cuts Heart Attack Risk

A new oral cholesterol-lowering drug reduced heart attack risk by 31% in a major clinical trial, offering a pill-based alternative to PCSK9 injections.
Cardiorespiratory Fitness Emerges as Strongest Exercise

New research highlights cardiorespiratory fitness, measured by VO2 max, as the single most important exercise-related predictor of long-term survival and
Seasonal Flu Vaccines May Soften H5N1 Bird Flu Severity

Emerging research suggests seasonal influenza vaccines may reduce severity of H5N1 bird flu infections through cross-reactive immunity, offering pandemic
Experimental Drug May Restore Movement

An experimental drug shows promise for restoring motor function after stroke by halting the cascade of neuronal death that follows the initial blood flow
Psychotropic Drugs in Dementia

New research finds half of dementia patients started on psychotropic drugs in hospitals or ERs remain on them a year later, raising deprescribing concerns.
Exercise Rivals Therapy and Medication for Depression

A major BMJ network meta-analysis finds walking, jogging, yoga and strength training significantly reduce depression, with effects comparable to standard
Anticholinergic Drugs Like Benadryl Linked

Common anticholinergic medications including Benadryl, sleep aids, and bladder drugs are associated with increased dementia risk in older adults, research
Fatal Delays in EpiPen Use for Childhood Food

Research presented at the Royal College of Emergency Medicine reveals dangerous delays in administering adrenaline autoinjectors to children with food
Organic Longevity Biotechnology

Organic longevity biotechnology is emerging as a new paradigm in anti-aging research, focusing on natural compounds and cellular rejuvenation strategies.
Physical Activity Interventions Effective

An overview of systematic reviews in BJSM finds physical activity interventions meaningfully reduce depression, anxiety and psychological distress across
Atopic Dermatitis Linked to Sleep Loss

New research finds adults with severe atopic dermatitis face higher risk of sleep disruption and memory difficulties, highlighting cognitive burden of eczema.
GLP-1 Weight Loss Success Hinges

Registered dietitians say structured nutrition guidance is essential for safe, sustainable weight loss with GLP-1 medications like semaglutide and tirzepatide.
EULAR Urges Doctors to Prescribe Exercise

Updated EULAR guidelines call physical activity counseling an integral part of standard care for patients with rheumatic and musculoskeletal diseases.
Noninvasive Proton Beam Therapy Cuts Dangerous Heart

Mayo Clinic's first-in-human trial shows proton beam radiation reduces ventricular tachycardia episodes by ~80%, offering hope for patients failing standard
How Statins Reduce Stroke Risk

Statins lower stroke risk by reducing LDL cholesterol and stabilizing arterial plaques. Learn who benefits most and the latest prevention guidelines.
FDA Single-Study Drug Approvals

FDA's expanded use of single-study drug approvals could speed access to new medicines, but raises questions about confirmatory evidence and post-market safety
Actinium-225 Alpha Therapy: Next-Generation

Actinium-225 alpha-emitter therapy is emerging as a next-generation theranostic for prostate cancer patients who have progressed on lutetium-177 treatment.
Waking EEG Patterns Reveal Brain Age Shifts Based

New research shows waking EEG brain age estimates shift measurably based on prior sleep in both children and adults, with implications for clinical assessment.
How Cardiorespiratory Fitness Amplifies the Brain Boost

New research suggests fitter individuals experience a stronger cognitive lift after exercise, with implications for brain health, memory, and dementia
New Preeclampsia Treatment May Safely Extend Pregnancy

A novel preeclampsia treatment from Cedars-Sinai may safely prolong pregnancy in women with severe early-onset disease, potentially reducing premature births.
Fezolinetant: Non-Hormonal Drug Targets Brain Pathway

Fezolinetant offers women a non-hormonal option for moderate to severe hot flashes by blocking the NK3 receptor pathway in the brain's thermoregulatory center.
Paleogenomics: How Ancient DNA Is Reshaping Modern

Ancient DNA from prehistoric remains is transforming how scientists understand pathogen evolution, human immunity, and modern disease risk.
Pediatric Sepsis Trial: Balanced Fluids vs Saline Show

NIH-funded clinical trial finds no significant difference between balanced crystalloids and normal saline for treating children with sepsis.
Pakistan HIV Outbreak in Children

At least 329 children infected with HIV in Pakistan's Sindh province amid medical negligence concerns. Reviewed by iMedic's medical editorial team.
Repurposed Drugs Show Promise for Aggressive Infant

Three clinically available drugs may transform treatment of MLL-rearranged infant leukemia, one of the deadliest childhood cancers, new research in HemaSphere
Gut Microbiome and Fitness: Why the Link Differs

New research suggests aerobic fitness is linked to gut microbiome diversity differently in men and women, pointing to sex-specific pathways for cardiometabolic
Bird Flu mRNA Vaccine Enters First UK Human Trial

UK launches first human trial of mRNA bird flu vaccine targeting H5N1 as global health authorities ramp up pandemic preparedness amid rising avian influenza
Transdermal Insulin Skin Cream

Researchers are developing a transdermal insulin cream that could deliver diabetes medication through the skin, potentially eliminating daily injections for
FDA Approves First Gene Therapy for Genetic Hearing

Regeneron's gene therapy becomes the first FDA-approved treatment to restore hearing in children with otoferlin-related genetic deafness through a single
WHO Prequalifies First Malaria Treatment

WHO has prequalified the first malaria treatment formulated for newborns and infants under 5kg, closing a critical gap in pediatric malaria care.
Artificial Neurons Successfully Communicate

Northwestern engineers create flexible printed artificial neurons that exchange signals with real brain cells, opening new paths for neurological disease
FDA Single-Trial Drug Approval Pathway

FDA shifts toward requiring only one adequate study for new drug approvals, accelerating patient access while raising questions about post-market evidence.
Fish Oil and Brain Health: New Study Raises Concerns

New research suggests omega-3 fish oil supplements may complicate recovery after repeated mild head injuries, challenging long-held assumptions about brain
WHO Warns Common Infections Increasingly Resist

WHO surveillance data shows a rising share of common bacterial infections no longer respond to standard antibiotics, threatening routine medical care globally.
WHO Warns Antibiotic Resistance Now Defeats Many Common

WHO report reveals a high share of common bacterial infections no longer respond to first-line antibiotics, threatening routine medical care globally.
FDA Shifts to Single Pivotal Trial Standard

FDA moves toward accepting one adequate well-controlled study to approve new drugs, aiming to speed access while raising questions about evidence quality.
Gut Reset Procedure May Prevent Weight Regain

A minimally invasive endoscopic gut procedure shows promise for helping patients maintain weight loss after discontinuing GLP-1 medications like semaglutide.
Gut Bacteria Linked to Depression

Harvard scientists identify how Morganella morganii gut bacterium may trigger depression by interacting with environmental pollutants to fuel inflammation.
Ketogenic Diet May Outperform Low-Fat Diet for Type 2

New evidence suggests very low-carbohydrate ketogenic diets may achieve higher rates of type 2 diabetes remission than traditional low-fat diets.
Beyond OTOF: What's Next in the Gene Therapy Pipeline

With the first gene therapy for genetic hearing loss approved, researchers are advancing treatments targeting GJB2, STRC, and other deafness genes.
Why Enjoyment Matters: How University Years Shape

New research finds that enjoyment of physical activity, not just fitness levels, predicts whether university students sustain exercise habits long-term.
Psilocybin Extends Cellular Lifespan and Boosts Survival

New npj Aging research shows psilocybin, the psychedelic compound in magic mushrooms, extends cellular lifespan and improves survival in aged mice.
Single-Dose Gene Therapy for Inherited Deafness

FDA approves Regeneron's AAV-based gene therapy for children with inherited OTOF deafness. Learn how a single cochlear injection can restore hearing.
AADC Deficiency Gene Therapy

Kebilidi (eladocagene exuparvovec) is the first FDA-approved gene therapy infused directly into the brain, treating ultra-rare AADC deficiency in children.
How Daylight Saving Time Worsens Insomnia

Daylight saving time transitions disrupt circadian rhythms, worsen insomnia, and increase cardiovascular risk. Experts call for permanent standard time.
Dual AAV Gene Therapy Restores Hearing

Children born with OTOF-related deafness are hearing and speaking for the first time after dual-AAV gene therapy — a landmark advance in pediatric otology.
Phage Therapy Breakthrough: Hidden Antibodies

Melbourne researchers discover patient antibodies can neutralize bacteriophages, explaining why some phage therapy fails against antibiotic-resistant superbug
Japanese Senolytic Drug Targets Aging Cells

Japanese researchers develop senolytic compounds that selectively eliminate aged cells, showing promise against age-related diseases in preclinical studies.
Skincare Compound Madecassic Acid Shows Promise

Researchers find madecassic acid from Centella asiatica, a common skincare ingredient, can disable antibiotic-resistant bacteria and restore drug sensitivity.
Blueroot Health Recalls Aller-C Supplements

Blueroot Health recalled Vital Nutrients Aller-C supplements over undeclared egg, hazelnut, and soy allergens. Reviewed by iMedic's medical editorial team.
Baby Teeth Reveal How Early Metal Exposure Shapes

Mount Sinai researchers use baby teeth and brain imaging to show how prenatal and infant exposure to metals like lead and manganese shapes brain development
Low-Plastic Diet Lowers Urinary Phthalates

New randomized trial in Nature shows a low-plastic diet meaningfully reduces urinary phthalate and bisphenol levels within weeks, raising policy and clinical
Antibiotic Use Linked to Lasting Gut Microbiome Changes

New research analyzing prescription data from nearly 15,000 individuals reveals how antibiotic exposure shapes gut microbiome composition and diversity over
Chronotype-Aligned Exercise Timing Cuts Cardiometabolic

New randomized trial in Open Heart finds that matching exercise timing to personal chronotype improves cardiometabolic markers in middle-aged adults at risk.
Epigenome Mapping Reveals How Insulin-Producing Cells

Lund University researchers have produced the most detailed epigenome map yet of pancreatic islet cells, revealing how gene regulation shifts in type 2
FDA Approves First Gene Therapy for Genetic Hearing

FDA approves Otarmeni, the first dual-AAV gene therapy for OTOF-related hereditary hearing loss, offering durable hearing restoration to children with DFNB9.
Anhedonia-Targeted Therapy: Reclaiming Pleasure Beats

A new therapy targeting the loss of pleasure (anhedonia) shows stronger improvements in depression and anxiety than standard cognitive behavioral therapy
SuperAgers: Why Some 80-Year-Olds

Scientists uncover why SuperAgers — adults over 80 with youthful memory — resist brain aging. Larger neurons, thicker cortex, and lifestyle factors all play a
Stem Cell-Derived Insulin Cells Show Promise for Type 1

Researchers advance stem cell-derived insulin-producing beta cells as a potential functional cure for type 1 diabetes, with encouraging early clinical trial
NIDDK Research Reveals Rising Type 2 Diabetes in Youth

New NIDDK-backed research shows type 2 diabetes in children and young adults progresses faster than in adults, with earlier complications and
Pediatric Fatty Liver Disease

NIDDK-funded research spotlights pediatric MASLD as the most common chronic liver disease in children, with rising prevalence tied to childhood obesity.
Cognitive Fitness: Evidence-Based Strategies

Harvard Health outlines evidence-based strategies for cognitive fitness. Learn how exercise, diet, sleep, and social engagement protect brain health across the
AI-Powered Accelerometers

Machine learning applied to wearable accelerometer data can estimate cardiorespiratory fitness in children and adolescents without formal exercise testing.
How NIH-Funded Research Transformed Childhood Cancer

Federal research funding has driven dramatic improvements in pediatric cancer survival, from leukemia cures to gene therapies for rare childhood diseases.
Low-Cost Talk Therapy Prevents Perinatal Depression

A major Johns Hopkins-led trial in Pakistan shows a simple cognitive behavioral intervention delivered by non-specialists can prevent anxiety and depression in
Depression and Anxiety in Peripheral Artery Disease

Depression and anxiety are strikingly common in peripheral artery disease and worsen outcomes. Here's what new AHA guidance means for patients and clinicians.
Brain-Shuttle Antibody Trontinemab Shows Rapid Amyloid

A next-generation antibody using Roche's brain-shuttle technology cleared amyloid plaques faster and with fewer side effects than existing Alzheimer's drugs.
FDA Overhauls Approval Pathway to Accelerate Rare

FDA introduces streamlined approval framework for rare disease gene therapies, offering new hope for patients with ultra-rare genetic conditions lacking
Extra Antibiotic Powder Fails to Reduce Infection Risk

New clinical trial finds that adding vancomycin powder during complex fracture surgery does not further reduce post-operative infection rates compared to
Implanted Nerve Stimulator for Sleep Apnea

A randomized controlled trial finds proximal hypoglossal nerve stimulation safely reduces obstructive sleep apnea severity, offering hope for CPAP-intolerant
Sleep Hygiene: Evidence-Based Practices for Better Rest

Harvard-backed sleep hygiene strategies that improve sleep quality, from consistent schedules to light exposure, caffeine timing, and bedroom environment.
Pediatric Brain Cancer Breakthrough

Pharmacy researchers advance pediatric brain cancer treatment with novel drug delivery systems designed to cross the blood-brain barrier in children.
Blood Test for Aggressive Brain Tumors

Researchers at the University of Sussex report a blood test capable of early detection of glioblastoma, the most aggressive brain tumor, potentially reducing
Lazertinib Plus Amivantamab: FDA Nod Marks South Korea's

Lazertinib (Leclaza), developed by South Korea's Yuhan Corporation, earned FDA approval with amivantamab as a first-line EGFR-mutated lung cancer therapy.
FDA Approves First Brain-Penetrating Enzyme Therapy

FDA approves Avlayah (tividenofusp alfa-eknm) as a first-of-its-kind enzyme replacement therapy targeting neurologic manifestations of Hunter syndrome (MPS II).
South Korea's Lecraza Wins FDA Approval

Lecraza (lazertinib) from South Korea's Yuhan secures FDA approval for EGFR-mutated lung cancer, marking a historic breakthrough for Korean pharma.
Obstructive Sleep Apnea Linked to Poor Muscle Quality

New research links obstructive sleep apnea to reduced muscle quality and increased bone fracture risk, reframing OSA as a whole-body disease.
Transgender vs Cisgender Body Composition and Fitness

A systematic review in BJSM examines body composition and physical fitness differences between transgender and cisgender individuals receiving hormone therapy.
GLP-1 Weight Loss Drugs Show Promise

Obesity drugs like semaglutide and tirzepatide are emerging as potential treatments for MASLD and MASH, the most common chronic liver diseases worldwide.
GLP-1 Drugs May Ease Anxiety

Emerging research suggests GLP-1 medications like semaglutide and tirzepatide, used for diabetes and obesity, may help reduce symptoms of anxiety and
Amyloid-Targeting Alzheimer's Drugs Show No Meaningful

A major Cochrane systematic review concludes that anti-amyloid drugs for Alzheimer's disease produce statistically significant but clinically insignificant
Nutrition During Cancer Treatment

Cancer treatment often causes nausea, taste changes, and appetite loss. Learn evidence-based nutrition strategies to maintain strength during chemotherapy and
High-Fat Diets May Let Gut Bacteria Cross

Emerging research suggests high-fat diets may weaken the blood-brain barrier, allowing gut bacteria to reach the brain and trigger neuroinflammation.
Personalized mRNA Pancreatic Cancer Vaccine Shows

Extended follow-up of autogene cevumeran, a personalized mRNA pancreatic cancer vaccine, shows durable T-cell responses linked to delayed recurrence in early
Sleep Deprivation and Deficiency

Sleep deprivation and deficiency raise risks of heart disease, diabetes, depression and accidents. Learn what NHLBI and WHO say about healthy sleep.
AI Breakthrough Detects Heart Disease and Cancer Years

Researchers develop AI systems that analyze routine scans to detect heart disease and cancer at their earliest, most treatable stages.
Clinic-Based Asthma Screening Boosts Pediatric Case

A cluster randomised trial in Uganda shows clinic-based screening substantially improves asthma detection in children and adolescents in primary care settings.
Mental Health Burden in People Living With HIV

New cross-sectional research highlights the substantial burden of depression, anxiety and stress among people living with HIV receiving antiretroviral therapy.
Alcohol and Stroke Risk: How Even Moderate Drinking

New analysis confirms alcohol raises stroke risk in a dose-dependent way. Learn what the evidence says about safe limits, mechanisms, and prevention.
Long COVID Risk in Children Doubles

New research finds children face roughly double the risk of long COVID after a second SARS-CoV-2 infection, raising concerns about cumulative pediatric impact.
Exercise as Depression Treatment

A landmark BMJ network meta-analysis finds walking, jogging, yoga and strength training significantly reduce depression symptoms, comparable to psychotherapy
Semaglutide May Preserve Lean Muscle Better

New comparative trial suggests Novo Nordisk's semaglutide preserves lean body mass more effectively than Eli Lilly's tirzepatide during weight loss.
Longevity Beauty: The Science

Longevity beauty merges skincare with cellular aging science. Learn how senolytics, NAD+ boosters, and epigenetic research are reshaping anti-aging.
Pediatric HIV Outbreak in Pakistan

Hundreds of children in Pakistan's Sindh province have been diagnosed with HIV, with medical authorities citing unsafe injections and reused syringes as primary
Pesticide Residues on Produce May Raise Lung Cancer Risk

New research suggests pesticide exposure from fruits and vegetables may contribute to rising lung cancer rates among younger non-smokers.
Pediatric Brain Cancer: UNC Pharmacy Team Advances

UNC Chapel Hill pharmacy researchers pursue new treatment approaches for pediatric brain tumors, the leading cause of cancer death in children.
Transdermal Estradiol for Menopausal Hot Flashes

Transdermal estradiol remains the most effective treatment for moderate to severe menopausal vasomotor symptoms, with a safety profile distinct from oral
Children's Bones Heal With Remarkable Remodeling Power

New trial evidence shows children's distal radius fractures heal and remodel so effectively that many displaced breaks may not need surgical reduction.
Japan Approves AI-Powered Brain MRI Tool to Speed Stroke

Japan's PMDA has approved an AI-powered brain MRI analysis platform, marking a significant step for automated neuroimaging in stroke and dementia care.
Theranostics Explained: Integrated Centers Combine

Theranostics pairs molecular imaging with targeted radioligand therapy, offering precision cancer treatment. Reviewed by iMedic's medical editorial team.
Probiotics and Healthy Diet May Support Cognitive

Emerging research suggests probiotics combined with a healthy diet may support cognitive function and brain health through the gut-brain axis.
Anti-Aging Drug Fails Human Trial

A highly anticipated anti-aging drug has failed to meet primary endpoints in human clinical trials, reshaping the outlook for the longevity pharmaceutical
Iron Age Mass Grave in Serbia

Bioarchaeologists analyze a 2,800-year-old mass grave in Serbia containing 77 victims, mostly women and children, offering rare insight into ancient trauma and
Japan Approves AI-Powered Brain Scan Device

Japan has approved a pioneering AI brain scan device to help diagnose depression, marking a major step toward objective psychiatric diagnostics.
Weight Loss Drug Cuts Heart and Liver Disease Risk

New clinical trial results show GLP-1 weight loss medications significantly reduce cardiovascular and liver disease risk in adults with obesity.
Sleep Deprivation Disrupts Gut Microbiota

New research links chronic sleep loss to gut microbiome disruption that may accelerate colorectal cancer progression via altered immune responses.
Enjoyment of Exercise Predicts Long-Term Fitness

New research shows enjoyment of physical activity is a stronger predictor of sustained exercise habits than fitness level itself among university students.
FDA 2025 Drug Approvals: Volume Holds Steady

Analysis of FDA 2025 novel drug approvals shows stable numbers but fewer first-in-class and breakthrough therapies compared to recent years.
Why You're Not Sleeping Through the Night

Harvard sleep experts identify four leading causes of nighttime awakenings, from stress and alcohol to sleep apnea and aging circadian rhythms.
FDA Approves Rare Kidney Disease Drug

FDA greenlights Travere's rare kidney disease drug after pivotal trial failed to show improvement in kidney function, reigniting debate over surrogate
FDA Requests Additional Safety Data on Lilly's Newly

FDA seeks post-approval safety data from Eli Lilly on its oral GLP-1 weight-loss pill, raising questions about long-term monitoring of new obesity medications.
Metformin May Help People With Type 1 Diabetes Use

A new clinical trial suggests metformin, a cheap drug for type 2 diabetes, may reduce insulin requirements in people with type 1 diabetes.
Transdermal Drug Delivery for Biologics

New transdermal delivery technologies may allow large-molecule drugs like insulin to be absorbed through the skin, potentially replacing injections for
New Legislation Aims to Strengthen FDA Authority

Proposed legislation seeks to reaffirm and expand FDA regulatory authority over dietary supplements, addressing safety and labeling concerns.
Fasting Blood Sugar of 103: What It Means

A fasting blood sugar of 103 mg/dL falls in the prediabetes range. Learn what this reading means, risk factors for progression, and evidence-based steps to
Personalized Psychobiotics: How Gut Bacteria

Research explores personalized psychobiotics as a new frontier in treating anxiety and depression by targeting the gut-brain axis with tailored probiotic
How FDA Price Considerations

FDA's evolving stance on drug pricing during approval reviews raises concerns about delays in bringing new treatments to patients and chilling pharmaceutical
Rett Syndrome Research: Scientists Identify Promising

New research from Texas Children's Hospital reveals a potential treatment pathway for Rett syndrome, a rare genetic disorder caused by MECP2 mutations affecting
How GLP-1 Drugs Are Reshaping Obesity

GLP-1 receptor agonists like semaglutide and tirzepatide are driving major growth in obesity and diabetes treatment, creating new challenges for managed care.
Buprenorphine for Opioid Addiction in Pregnancy

New research confirms buprenorphine use during pregnancy for opioid addiction does not increase neurodevelopmental disorder risk in children, including ADHD and
Dietary Fat Quality Over Quantity

New research shows the type of fat you eat matters more than how much. Palmitic acid and oleic acid play distinct roles in type 2 diabetes development.
Pediatric Medicine Breakthroughs

Recent pediatric medicine breakthroughs in gene therapy, childhood cancer treatment, and neonatal care are reshaping how doctors treat the most vulnerable
How Circadian Rhythm Misalignment Drives Insomnia

New research links circadian rhythm timing disruptions to specific insomnia symptoms, offering insights into personalized sleep disorder treatments.
How Pregnancy Complications Can Signal Long-Term Health

Pregnancy complications like preeclampsia and gestational diabetes can increase women's risk of heart disease, stroke, and type 2 diabetes decades later.
How Hormonal Disorders Affect Fertility

Endocrine disorders like PCOS, thyroid disease, and adrenal conditions can impair fertility. Learn how hormonal management improves pregnancy outcomes.
Personalized CRISPR Base Editing

A personalized CRISPR base editing therapy designed for a single patient marks a new era in treating rare genetic diseases. What this means for medicine.
Flu Vaccination Lowers Heart Attack and Stroke Risk

New evidence confirms influenza vaccination significantly reduces cardiovascular events including heart attack and stroke, even among patients who experience
FDA Novel Drug Approvals in Pediatrics

The FDA has approved several novel therapies for pediatric patients in 2026, expanding treatment options for childhood conditions from epilepsy to rare
Nutritional Psychiatry: How Your Diet Directly Affects

Nutritional psychiatry reveals how diet quality impacts brain function, mood, and mental health. Learn which foods support cognitive health and why nutrition
Miniature CRISPR System Enables Precision Gene Editing

NIH-funded researchers develop a smaller CRISPR system that fits inside delivery vehicles for targeted gene editing directly in the body.
How the Brain's Glymphatic System Clears Toxic Waste

New research highlights how the brain's glymphatic system removes toxic proteins like amyloid-beta during deep sleep, with implications for Alzheimer's
How Bread and Carbohydrates May Cause Weight Gain

New research reveals how carbohydrate-rich foods like bread may reshape metabolism and promote weight gain even without increasing total calorie intake.
Gut Microbiome Reset Reduces Brain Inflammation

New research shows resetting the gut microbiome can significantly reduce neuroinflammation, opening doors for treating Alzheimer's, MS, and other neurological
FDA Approves Sparsentan as First-Ever Treatment

The FDA has approved sparsentan (Filspari) as the first treatment specifically indicated for FSGS, a rare kidney disease with no prior approved therapies.
Menopause Drug Market Surges

The menopause drug market is experiencing unprecedented growth as new nonhormonal therapies like fezolinetant join HRT options, giving women more treatment
GLP-1 Drugs May Improve Liver Health Independent

New mouse study finds GLP-1 receptor agonists improve liver health through mechanisms beyond weight loss, offering hope for NAFLD treatment.
Antibiotics Can Trigger Bacteria to Release Inflammatory

New research reveals antibiotics may cause bacteria to shed membrane vesicles that fuel inflammation, potentially worsening infection outcomes.
AI and Optogenetics: A New Frontier

South Korean researchers combine AI algorithms with optogenetics to enable precision diagnosis and targeted treatment of Parkinson's disease.
Largest Pregnancy Sickness Study Reveals

The largest genetic study of pregnancy sickness identifies new genes linked to hyperemesis gravidarum, building on the landmark GDF15 discovery.
GLP-1 Drugs for Weight Loss

GLP-1 receptor agonists like semaglutide and tirzepatide are transforming weight loss treatment and showing benefits for heart, kidney, and liver disease.
School-Based Group Motivational Interviewing Shows

A BMJ feasibility study finds school-based group motivational interviewing is acceptable and feasible for reducing sugar-sweetened beverage intake among
Gestational Diabetes and Insulin Resistance

New insights into gestational diabetes insulin treatment and how nocturnal blood sugar regulation impacts insulin resistance and maternal-fetal outcomes.
Weight Regain After Stopping Obesity Medication

A BMJ systematic review reveals how much weight people regain after discontinuing weight management medications like GLP-1 receptor agonists.
Kidney Disease Amplifies Cardiovascular Risk

New NOAH-AFNET 6 analysis reveals kidney disease significantly increases cardiovascular event risk in patients with device-detected atrial fibrillation.
Early Morning Exercise May Significantly Lower Obesity

New research suggests exercising in the early morning hours may offer greater protection against obesity and type 2 diabetes than working out later in the day.
Inhaled RNA Therapy Shows Promise for Reducing Lung

New inhaled RNA-based treatment reduces lung inflammation in preclinical models, offering hope for post-infection respiratory damage.
Human Insulin for Diabetes

Regular human insulin (R insulin) is gaining renewed attention for diabetes management. Learn why some physicians advocate for its use alongside modern analogs.
When Your Diet Is Not Enough

Experts explain when a balanced diet falls short and nutritional supplements become necessary, including key deficiency signs and evidence-based guidance.
GLP-1 Weight-Loss Drugs May Relieve Arthritis Pain

Doctors report GLP-1 weight-loss medications like semaglutide may reduce arthritis pain through anti-inflammatory effects beyond weight reduction alone.
Pediatric Precision Nuclear Medicine

New partnerships are bringing theranostic nuclear medicine to pediatric oncology, combining molecular diagnostics with targeted radiotherapy for children.
Jaw Cramps and Hypoglycemia: The Overlooked Warning Sign

Jaw cramps can signal dangerously low blood sugar in people with type 2 diabetes on insulin. Learn why this symptom occurs and how to manage hypoglycemia
23andMe Identifies Genetic Markers

23andMe research identifies genetic variants linked to how patients respond to GLP-1 weight loss drugs like semaglutide, advancing pharmacogenomics.
FDA Regulatory Reform: What New Accelerated Approval

FDA accelerated approval pathway faces major reforms. Learn how regulatory changes affect drug access, confirmatory trials, and patient safety.
Probiotics May Boost GLP-1 Drug Effectiveness

New research suggests probiotics could enhance the weight loss effects of GLP-1 receptor agonists like semaglutide by improving gut microbiome composition.
GLP-1 Weight Loss and Side Effects Linked

New research links genetic variations to how patients respond to GLP-1 receptor agonists, explaining differences in weight loss outcomes and side effects.
New Alzheimer's Drug Mechanisms Show Promise

Recent Nature research highlights innovative pharmaceutical approaches targeting amyloid clearance in Alzheimer's disease, offering hope for earlier and more
Sulthiame for Sleep Apnea: Clinical Trial Shows Drug

A clinical trial finds sulthiame, a carbonic anhydrase inhibitor, significantly reduces breathing pauses in obstructive sleep apnea patients unable to tolerate
New Anti-Seizure Medication Transforms Lives

A novel anti-seizure drug is showing remarkable results for children with developmental and epileptic encephalopathies, offering improved daily functioning and
Topical Treatments for Rheumatoid Arthritis Joint Pain

Evidence-based guide to topical treatments for rheumatoid arthritis joint pain, including NSAIDs, capsaicin, and emerging therapies.
Why Sleep Is Essential: How It Protects Your Brain

New NIH insights explain why sleep is critical for brain health, cardiovascular function, and immunity — and what happens when you don't get enough.
Depression and Anxiety Linked to Lower Antihypertensive

New NHANES analysis reveals adults with hypertension who have depression or anxiety are less likely to use antihypertensive medications consistently.
How Your Gut Microbiome May Drive Type 2 Diabetes

New NIDDK-funded research explores the gut microbiome's role in insulin resistance and type 2 diabetes, revealing potential targets for prevention and
Tens of Thousands of Heart Attacks

Johns Hopkins research finds guideline-directed use of cholesterol-lowering drugs could prevent tens of thousands of cardiovascular events annually in the US.
GLP-1 Weight-Loss Drug Side Effects

GLP-1 drugs like semaglutide cause side effects beyond nausea. Learn about 'Ozempic face,' muscle loss, and how to reduce risks during treatment.
FDA's New Drug Pricing Role: How Cost Considerations

The FDA's expanding role in drug pricing adds new uncertainty to the approval process. What this means for pharmaceutical companies and patients.
FDA and Children's Hospitals

How FDA programs and children's hospitals are accelerating pediatric medical device development to close the gap in child-specific treatment technologies.
Germany Launches National Health Registry

Germany's new national health registry tracks injuries across men's and women's Bundesliga. First results reveal key patterns in professional football health.
FDA Food and Dietary Supplement Labeling

Understanding FDA regulation of health claims on food and dietary supplement labels, including the difference between approved and unauthorized claims.
Cholesterol Targets for Secondary Prevention

New discussion on optimal LDL cholesterol targets for secondary prevention of cardiovascular events. Reviewed by iMedic's medical editorial team.
How Federal Research Funding Has Driven Major Pediatric

Federal research funding has enabled critical pediatric breakthroughs from childhood cancer treatments to newborn screening. Why continued investment matters.
Exercise Combined With Functional Foods

New research highlights how combining regular exercise with functional foods and supplements may offer synergistic benefits for postmenopausal women's health.
Breakthrough Treatments for Rare Neurological Disorders

New treatment approaches for rare pediatric neurological disorders offer hope. Learn about breakthrough therapies, early diagnosis, and outcomes for children.
Congenital Adrenal Hyperplasia and Fertility

Congenital adrenal hyperplasia (CAH) can affect fertility, but pregnancy is possible with proper management. Reviewed by iMedic's medical editorial team.
FDA Pediatric Drug Approvals

The FDA has approved several novel pediatric drugs in 2026, addressing rare diseases and unmet needs in children's medicine.
Frailty Index Strongly Linked to Low Back Pain

New BMJ cross-sectional analysis reveals a significant association between higher Frailty Index scores and low back pain prevalence in adults over 45.
How the WHO Selects Influenza Vaccine Strains

WHO has announced updated influenza vaccine composition for the upcoming northern hemisphere flu season. Reviewed by iMedic's medical editorial team.
Children Involved in Family Court Proceedings Face

New research links family court involvement to increased self-harm risk in children, highlighting the need for better mental health support during custody and
Dietary Supplement Recall Over Undeclared Allergens

Blueroot Health recalls Vital Nutrients Aller-C supplements for undeclared egg, hazelnut, and soy — raising broader concerns about supplement safety and
Gut Bacteria May Trigger ALS and Frontotemporal Dementia

New research reveals gut microbes produce harmful sugars that spark immune responses damaging the brain, potentially triggering ALS and frontotemporal dementia.
Machine Learning Models Improve Stroke Risk Prediction

New interpretable machine learning models outperform traditional CHA₂DS₂-VASc scores for predicting stroke risk in newly diagnosed atrial fibrillation patients.
Light Therapy for Insomnia: How Bright Light Exposure

Light therapy is emerging as a drug-free treatment for insomnia by resetting circadian rhythms. Learn how timed bright light exposure improves sleep quality.
Genetic Variants in 1 in 10 People May Blunt GLP-1 Drug

New research finds common genetic variants may reduce how well GLP-1 receptor agonists lower blood sugar, pointing toward pharmacogenomic prescribing.
ACC/AHA Release Major Update

The ACC and AHA have issued updated guidelines for managing lipids and cholesterol, emphasizing earlier intervention and expanded statin eligibility.
NIH Unveils New Strategic Vision for Heart, Lung, Blood

The NIH's NHLBI outlines bold research priorities for heart, lung, blood, and sleep disorders, emphasizing precision medicine and health equity.
Managing Multimorbidity During COVID-19

A qualitative study reveals how physicians in India adapted multimorbidity management during COVID-19, offering lessons for future pandemic preparedness.
FDA Drug Approval Pipeline: Key New Therapies Expected

A look at the most anticipated FDA drug approvals in the current pipeline, including treatments for cancer, rare diseases, and metabolic disorders.
New Drug Offers Breakthrough

A new drug is transforming outcomes for children with severe epilepsy, significantly reducing seizure frequency and improving quality of life for families.
Wegovy Now Prescribed by GPs to Prevent Heart Attacks

GPs can now prescribe Wegovy (semaglutide) to prevent heart attacks and strokes in eligible patients, following landmark SELECT trial evidence.
FDA Accepts Brain Cancer Imaging Drug Application

FDA accepts Telix Pharmaceuticals' application for a novel PET imaging agent targeting brain cancer, potentially improving glioma diagnosis and surgical
Wegovy Oral Pill Launch: How the First GLP-1 Weight Loss

Novo Nordisk launches oral Wegovy pill, bringing GLP-1 weight loss treatment beyond injections. What patients need to know about the new semaglutide tablet.
Radioligand Therapy in Pediatric Cancer

Radioligand therapy is emerging as a precision treatment for pediatric cancers, offering targeted radiation with fewer side effects than conventional
Rising Nighttime Temperatures Threaten Global Sleep

Leading sleep scientists warn that nighttime warming is disrupting sleep for billions worldwide, with serious implications for public health and chronic
Chronic Insomnia in Women: The Hidden Link

New research highlights how chronic insomnia disproportionately affects women's cardiovascular and mental health, with CBT-I emerging as first-line treatment.
Oral Semaglutide vs. Orforglipron

A clinical comparison of oral semaglutide (Wegovy) and orforglipron for obesity and overweight treatment, covering efficacy, mechanisms, and practical
AI Models That Predict Pregnancy Complications

New AI models developed by maternal-fetal medicine specialists show promise in predicting pregnancy complications like preeclampsia and preterm birth earlier.
Undeclared Food Allergens: Why Hidden Tree Nuts

Undeclared allergens in food products remain a leading cause of recalls and allergic emergencies. Learn how hidden tree nuts put millions at risk.
Somatostatin in the Brain Regulates Immune Cells

New research reveals somatostatin directly regulates brain immune cells to reduce neuroinflammation, opening a potential treatment path for dementia using
How Antibiotics Affect Your Gut Microbiome

Antibiotics can temporarily wipe out beneficial gut bacteria. Learn how the microbiome recovers, what research shows, and how to protect gut health during
FDA Accelerated Approval Reforms

FDA reforms to the accelerated approval pathway aim to strengthen post-market confirmatory trials while preserving fast access to breakthrough therapies.
Egg Rejuvenation: New Research Tool

Scientists develop a new tool to study aging eggs, potentially paving the way for treatments that could extend female fertility windows.
Does Evening Exercise Really Hurt Your Sleep?

New insights on whether exercising at night disrupts sleep quality. Research suggests the timing matters less than you think.
New Drug Class Targets Resistant High Blood Pressure

Aprocitentan, a dual endothelin receptor antagonist, offers new hope for patients with resistant hypertension unresponsive to conventional medications.
New Flu Treatment Protects Lungs and Cuts Bacterial

A novel influenza treatment strategy shields lung tissue from bacterial pneumonia by boosting host defenses rather than targeting the virus directly.
Structural Racism and Historic Redlining Linked

New research from the University at Buffalo reveals how historic redlining and ongoing structural racism drive higher diabetes prevalence in American
Can Exercise Compensate for Poor Sleep?

New research explores whether exercise can offset the health damage of poor sleep — and how to balance both for optimal health outcomes.
Does Skipping Sleep Cancel Out Your Workout?

New research explores how sleep and exercise interact, revealing why sacrificing rest for a workout may do more harm than good.
High-Flow Nasal Oxygen After Cardiac Surgery Fails

The NOTACS trial found high-flow nasal oxygen therapy did not improve survival or functional independence after cardiac surgery in high-risk patients.
Fertility Awareness-Based Methods

Fertility awareness-based methods (FABMs) for pregnancy prevention — how they work, effectiveness rates, and what the latest evidence says about natural family
Game-Based Afterschool Exercise Programs Boost

A randomized controlled trial finds that a 12-week game-based afterschool physical activity program significantly improves fitness in children aged 9-10.
Why Lifestyle Habits Outperform Supplements

Aging researchers increasingly favor exercise, sleep, and diet over supplements for longevity. Here's what the science actually supports.
Alzheimer's Drug Development Enters New Era

New pharmaceutical approaches to Alzheimer's disease target neuroinflammation, tau protein, and synaptic repair, marking a paradigm shift beyond traditional
Measles Outbreak in Bangladesh Kills Dozens

A deadly measles outbreak in Bangladesh has claimed the lives of at least 38 children, highlighting dangerous vaccination coverage gaps in South Asia.
Exercise Duration Matters

New UBC study finds that how long you exercise matters more than exercise type for blood sugar management in newly diagnosed type 2 diabetes.
WHO Report: Progress on Reducing Child Deaths

New WHO estimates show 4.9 million children died before age five in 2024, most from preventable causes. Reviewed by iMedic's medical editorial team.
Sublingual Aspirin Shows Promise

New sublingual aspirin formulation delivers antiplatelet effects significantly faster than standard oral aspirin in clinical trials for suspected heart attacks.
Breakthrough Osteoarthritis Drug Shows Major Success

A new disease-modifying osteoarthritis drug has shown significant joint structure preservation and pain relief in a large international trial, marking a
FDA Approves New Generic Diabetes Drug

FDA grants approval for a new generic diabetes medication, potentially expanding affordable treatment access for millions of Americans with type 2 diabetes.
Weight-Loss Drugs Linked to Lower Risk

New research finds GLP-1 receptor agonists used for weight loss are associated with reduced risk of worsening depression and anxiety symptoms.
Why Americans Are Demanding Oral Weight-Loss Pills

Growing demand for oral GLP-1 weight-loss pills driven by cost, convenience, and injection fatigue. What the shift means for obesity treatment.
FDA Approves Generic Combination Drug

FDA grants approval for a new generic combination drug targeting both hypertension and high cholesterol, potentially improving adherence and lowering costs.
Deep Brain Stimulation Shows Promise

Deep brain stimulation (DBS) is being explored as a potential treatment for dementia in Alzheimer's and Parkinson's disease, targeting memory circuits in the
Dravet Syndrome Treatment

New treatments for Dravet syndrome and severe childhood epilepsy are dramatically improving seizure control and quality of life for affected children and
Capping Insulin at $35 Per Month Significantly Improves

New study finds that capping insulin costs at $35 per month leads to significantly better medication adherence among people with type 2 diabetes.
Combined Ultrasound and Shockwave Therapy Shows Promise

New research finds combining low-intensity pulsed ultrasound with extracorporeal shock wave therapy reduces pain and inflammation in knee osteoarthritis
EMA Backs First Combined Flu-COVID mRNA Vaccine

European Medicines Agency recommends first combined influenza-COVID mRNA vaccine, diverging from FDA which declined to review the application.
Why Women Face Higher Insomnia Risk at Every Stage

Women are significantly more likely to develop insomnia than men. New research explores how hormonal changes across the lifespan drive sleep disruption.
Antibody-Drug Conjugates: How Targeted Cancer Therapies

Antibody-drug conjugates (ADCs) are transforming cancer treatment by delivering chemotherapy directly to tumor cells, with new approvals expanding into lung
Should You Skip Your Workout

When sleep and exercise compete for your time, which should you prioritize? New insights reveal how to balance both for optimal health.
Revolutionary Sickle Cell Gene Therapy

A New Jersey man is now pain-free after receiving a revolutionary sickle cell gene therapy at CHOP, highlighting the real-world success of FDA-approved
CRISPR Gene-Editing Therapy Safely Lowers Cholesterol

First-in-human trial shows CRISPR-based gene editing can safely reduce LDL cholesterol and triglycerides, opening a new frontier in cardiovascular disease
How Physical Fitness Shapes the Gut Microbiome

New research reveals distinct gut microbiota profiles in children with high vs. low physical fitness and activity levels, suggesting exercise shapes gut health
Why a Diverse Exercise Routine May Help You Live Longer

Large cohort study finds that variety in physical activity types is linked to lower mortality risk, beyond total exercise volume alone.
Your Gut Microbiome Holds the Key to Anti-Aging

Scientists reveal how gut microbes influence aging and longevity, with new strategies to maintain a youthful microbiome throughout life.
Japanese Drug Targets Cellular Aging

A Japanese research team has identified a drug candidate that targets senescent cells, potentially slowing aging at the cellular level.
Exercise Variety Matters: Mixing Activity Types Linked

New research from two large cohort studies shows that varying physical activity types — not just exercising more — is linked to significantly lower mortality
FDA Regulatory Delays and Staff Exodus

FDA faces mounting criticism over regulatory delays and staff departures that could slow drug approvals and threaten public health safety standards.
Child Mortality Under Five

An estimated 4.9 million children died before age five in 2024, including 2.3 million newborns. Experts warn that progress in reducing child mortality is
Exercise at Work: How Workplace Physical Activity Lowers

New research shows that integrating exercise into the workday significantly reduces chronic disease risks including cardiovascular disease and type 2 diabetes.
Nipah Virus Vaccine Enters First Human Trial

Japan begins the world's first human clinical trial of a Nipah virus vaccine, marking a major milestone in combating one of the deadliest known pathogens.
Sleep vs. Exercise: Which Matters More for Your Health

New research explores the complex relationship between sleep and exercise, revealing how to optimize both for cardiovascular health and longevity.
How Just 5 Extra Minutes of Exercise

New research suggests small daily changes — just 5 more minutes of moderate exercise and 10 extra minutes of sleep — may meaningfully reduce cardiovascular
Baxdrostat Shows Strong Results

Baxdrostat, a new aldosterone synthase inhibitor, demonstrates significant blood pressure reduction in patients with treatment-resistant hypertension in global
3D Bioprinted Cartilage Cell Therapy Shows Promise

South Korean researchers achieve first successful 3D cartilage cell therapy for osteoarthritis, opening new doors in regenerative joint treatment.
Diabetes Drugs May Slow Cognitive Decline

GLP-1 receptor agonists originally developed for type 2 diabetes show promise in slowing cognitive decline in early-stage Alzheimer's disease patients.
Scientists Uncover Why mRNA COVID Vaccines Rarely

Stanford researchers identify the two-step immune mechanism behind rare mRNA vaccine-linked myocarditis in young men, pointing toward safer future vaccine
Vitamin B12 and Longevity: How This Essential Nutrient

New research highlights vitamin B12's critical role in longevity and healthy aging, from brain health to cellular energy production.
Peeled Garlic Recalled Over Botulism Risk

Certain lots of peeled garlic recalled due to possible Clostridium botulinum contamination. Learn about botulism symptoms, risks, and food safety precautions.
Metformin May Mimic Exercise Benefits in Prostate Cancer

New research suggests metformin activates the same energy-sensing pathway as exercise in prostate cancer, raising hopes for patients unable to stay physically
Can Exercise Treat Depression

New research suggests structured exercise may be as effective as psychotherapy for treating depression. Reviewed by iMedic's medical editorial team.
Online Mental Health Programs Show Significant

New research shows online mental health treatment programs can significantly reduce depression and anxiety symptoms in people living with multiple sclerosis.
Depression and Anxiety in People Living With HIV

Studies show high rates of depression, anxiety, and stress among people living with HIV. Experts call for integrated mental health screening at ART centres.
New Alzheimer's Drug Approach Targets Brain Rewiring

A novel Alzheimer's drug strategy focuses on restoring synaptic connections and brain plasticity rather than solely clearing amyloid plaques.
RNA Interference Therapy for Resistant Hypertension

New RNA interference drug zilebesiran targets liver-produced angiotensinogen to lower blood pressure in patients who fail standard treatments.
Hong Kong's New Drug Approval Pathway

Hong Kong plans a new independent drug approval framework to attract global pharma companies and accelerate patient access to innovative medicines.
Pediatric Cardiomyopathy: Why Identifying the Cause Is

New guidance from the American Heart Association emphasizes that identifying the underlying cause of cardiomyopathy in children is essential for effective
Generic Semaglutide Launches in India

Natco Pharma launches generic semaglutide in India, expanding access to the blockbuster GLP-1 drug used for type 2 diabetes and weight management.
Chronic Kidney Disease in Diabetes

New NIDDK-funded research highlights advances in early detection and prevention of diabetic kidney disease, the leading cause of kidney failure worldwide.
Sleep Medicine Research: How

Recent advances in sleep medicine research are reshaping how clinicians diagnose and treat sleep disorders, from obstructive sleep apnea to insomnia.
Custom-Made CRISPR Gene-Editing Therapy for Children

A groundbreaking clinical trial will test personalized CRISPR gene-editing therapies designed for individual children with rare genetic disorders.
FDA Dietary Supplement Labeling

FDA regulation of dietary supplement and food labeling claims faces scrutiny. Learn how current rules protect consumers and where gaps remain.
AI Algorithm Can Now Analyze Physical Activity

A new AI-based algorithm can assess physical activity levels and health-related fitness in youth, offering potential for early intervention in childhood health.
Mental Health Intervention Reduces Severe Depression

A University of Texas study finds a targeted mental health intervention significantly reduces severe depression and anxiety symptoms among vulnerable
Texas Children's Hospital Delivers Breakthrough

Texas Children's Hospital provides a new breakthrough treatment for a patient with a rare neurological disorder, offering hope for pediatric neurology care.
Aldosterone Synthase Inhibitors

Aldosterone synthase inhibitors represent a new class of antihypertensive drugs targeting hormone-driven blood pressure elevation in treatment-resistant
Sickle Cell Disease: Specialized Treatment Centers

Specialized treatment centers like CHOP report revolutionary outcomes for sickle cell patients, with some achieving complete pain resolution after gene-based
COVID-19 mRNA Vaccines May Spark Immune Response

University of Florida researchers discover COVID-19 mRNA vaccines can trigger immune pathways with potential anti-cancer activity, opening new avenues for
Colorectal Cancer Research: How Precision Oncology

New colorectal cancer research focuses on precision oncology approaches to improve survival rates. Learn about emerging treatments and screening advances.
Why a Leading Longevity Researcher Skips Supplements

A longevity researcher relies on three simple habits instead of supplements for healthy aging. Learn what the science says about exercise, sleep, and diet.
Japanese Anti-Aging Drug Shows Promise

A Japanese drug is showing potential to combat aging at the cellular level. Learn about the science behind this longevity research breakthrough.
Menopause Hormone Therapy and Brain Health

New research challenges long-held beliefs about menopause hormone therapy and cognitive decline. Learn what science now says about HRT, brain health, and
How Exercise and a Healthy Diet Can Restore Optimal

New research confirms that regular exercise and a balanced diet can significantly improve physical and mental well-being in older adults, even after years of
Alzheimer's Drug Innovation: How Dual-Target Therapies

New dual-target Alzheimer's therapies combining amyloid and tau approaches show promise in reshaping dementia treatment strategies.
Gene-Edited Sickle Cell Therapy

Revolutionary gene-editing therapy for sickle cell disease delivers lasting pain relief, with patients reporting complete elimination of vaso-occlusive crises
Japan Launches First Human Trial of Nipah Virus Vaccine

Japan begins the world's first human clinical trial of a Nipah virus vaccine, targeting one of the deadliest known pathogens with fatality rates up to 75%.
Preventive Circadian Medicine

A new framework for preventive circadian medicine proposes routine sleep checkups to detect health risks early. Learn how circadian disruption affects disease.
Personalized mRNA Cancer Vaccines

Personalized mRNA cancer vaccines are advancing rapidly through clinical trials, leveraging COVID-19 pandemic technology to create individualized tumor
Bipartisan Insulin Cost Cap Bill

A new bipartisan bill aims to cap insulin costs at $35/month for all Americans. Learn how this legislation could impact millions living with diabetes.
First Personalized CRISPR Therapy Saves Infant Life

A baby with a severe genetic disorder became the first person treated with a fully personalized CRISPR gene therapy, marking a new era in precision medicine.
Scientists Identify Key Protein That Drives Brain Aging

Researchers discover that the protein FTL1 weakens brain cell connections during aging and demonstrate methods to reduce its effects in animal models.
Video Gaming Linked to Better Cognitive Performance

NIH-supported research suggests video gaming may improve cognitive performance in children, including memory and impulse control. Learn what the science says.
Eli Lilly's New Oral Weight-Loss Pill

Eli Lilly receives FDA approval for a new oral weight-loss pill, marking a major shift from injectable GLP-1 therapies. Learn how it works and who may benefit.
WHO Announces Influenza Vaccine Composition

WHO releases updated influenza vaccine strain recommendations for the upcoming northern hemisphere flu season, guiding global vaccine production.
FDA Approves Avlayah for Neurologic Hunter Syndrome

The FDA has approved Avlayah (tividenofusp alfa) to treat neurological manifestations of Hunter syndrome, marking a major advance for MPS II patients.
Childhood Brain Cancer Research Breakthrough

An international study reveals new molecular targets in childhood brain cancers, potentially transforming treatment for pediatric patients with medulloblastoma.
FDA Approves Kresladi: First Gene Therapy

FDA approves Kresladi (marnetegragene autotemcel), the first-ever gene therapy for severe LAD-I, offering a potential cure for children with this rare and often
Vivid Dreams May Be the Secret

New neuroscience research reveals that vivid, immersive dreaming may enhance perceived sleep quality and restfulness, even when brain activity tells a different
Depression and Anxiety in Opioid Dependence

New research reveals key psychosocial factors driving depression and anxiety in opioid-dependent patients, highlighting the need for integrated mental health
Gender-Affirming Treatments Linked to Reduced Depression

A new retrospective cohort study published in Frontiers examines how gender-affirming treatments affect depression and anxiety symptoms in transgender
Type 2 Diabetes Remission Through Lifestyle Changes

New digital series highlights evidence-based lifestyle interventions that can achieve type 2 diabetes remission. Reviewed by iMedic's medical editorial team.
Programmable DNA Smart Drug Targets Cancer Cells

Scientists develop a synthetic DNA-based drug system that activates only when detecting specific tumor markers, offering a new era of precision cancer therapy.
New Cholesterol-Lowering Drugs and Gene Therapy

New cholesterol-lowering treatments including gene therapy and novel drugs are transforming cardiovascular disease prevention in 2026.
Fasting-Mimicking Diet Shows Promise

A new clinical trial finds a 5-day fasting-mimicking diet may reduce symptoms and inflammation in Crohn's disease patients. Here's what researchers discovered.
Pet Longevity Industry Surges

The pet longevity industry is booming as anti-aging drugs and GLP-1 treatments expand into veterinary medicine, promising longer and healthier lives for pets.
Driving With Arthritis: How to Stay Safe

Arthritis pain can impair driving safety. Learn evidence-based tips for comfortable, safe driving with joint pain, stiffness, and reduced grip strength.
New Drug for Severe Childhood Epilepsy

A new drug is giving hope to children with severe epilepsy, reducing seizures and improving quality of life. Learn about the latest treatment advances.
Gut Microbiome Blood Markers May Detect Cognitive

Six gut-related blood metabolites may identify early cognitive impairment, linking the gut-brain axis to dementia detection and prevention.
WHO: 4 in 10 Cancer Cases Could Be Prevented Worldwide

A new WHO and IARC global analysis finds up to 40% of cancer cases are preventable through modifiable risk factors like tobacco, alcohol, and obesity.
Breakthrough Pediatric Kidney Therapy

University of Iowa researchers develop promising new pediatric kidney therapy that could transform treatment for children with kidney disease.
Type 1 Diabetes Clinical Trials

New type 1 diabetes clinical trials explore immunotherapy approaches beyond teplizumab, aiming to prevent beta cell destruction and delay disease onset.
Colchicine for Heart Disease

Colchicine, a low-cost gout medication, shows promise in reducing heart attack and stroke risk by targeting inflammation. Learn about the evidence.
High-Dose Flu Vaccine Linked to Lower Alzheimer's Risk

A new study finds high-dose influenza vaccination significantly reduces Alzheimer's dementia risk compared to standard-dose flu shots. Here's what it means.
Short Exercise Bursts Could Boost Memory

New research suggests short bursts of exercise may significantly enhance memory and cognitive function. Learn how brief workouts affect the brain.
Depression Research 2026: New Insights Into Brain

Latest NIMH research on depression reveals new understanding of brain mechanisms, treatment advances, and why early intervention matters for the 280 million
Insomnia and Depression: Why 'Just Get More Sleep' Fails

New research reveals the bidirectional link between insomnia and depression, explaining why simply sleeping more doesn't resolve either condition.
New Osteoarthritis Pain Drug Candidate

City St George's partners with Paradigm Biopharmaceuticals to study the mechanism behind injectable pentosan polysulfate sodium (iPPS) for osteoarthritis pain
Lead in Children's Clothing: Study Finds Dangerous

New research finds lead levels exceeding US safety limits in children's clothing from major retailers, raising concerns about toxic exposure through fast
Men's Mental Health: Why Depression and Anxiety Go

Men's depression and anxiety often go unrecognized due to atypical symptoms and stigma. Learn the warning signs, risk factors, and how men can get help.
New Oral GLP-1 Weight Loss Pill Gets FDA Approval

The FDA has approved another oral GLP-1 weight loss pill with broader prescribing criteria, expanding access to obesity treatment beyond injectable options.
Stopping GLP-1 Receptor Agonists Linked

New BMJ Medicine study finds discontinuing GLP-1 receptor agonists may increase major cardiovascular events in adults with type 2 diabetes.
How the Body Traps Sleeping Tuberculosis

Scientists use spatial mapping to reveal how immune cells organize around latent tuberculosis bacteria in granulomas, opening new paths for TB treatment.
UT Health Launches Major Clinical Trial Testing

UT Health San Antonio launches one of the largest trials testing potential longevity drugs. Learn about the science of aging interventions and what this means.
WHO Addresses Planned Hepatitis B Birth Dose Vaccine

WHO issues statement on a planned hepatitis B birth dose vaccine trial in Guinea-Bissau, highlighting global efforts to eliminate mother-to-child transmission.
Cancer Research in 2026: New Funding, Immunotherapy

Major cancer research advances in 2026 include expanded immunotherapy combinations, new targeted therapies, and increased NCI funding.
Anti-Inflammatory Diet: How Food Choices

Learn how an anti-inflammatory diet rich in fruits, vegetables, and omega-3 fatty acids can reduce chronic inflammation linked to heart disease, diabetes, and
Best Supplements for Gut Health

Evidence-based guide to gut health supplements including probiotics, prebiotics, and postbiotics. Learn which supplements have real scientific support in 2026.
FDA 2025 Drug Approvals: A Record-Breaking Year

The FDA approved a landmark number of novel drugs in 2025, with oncology and rare diseases leading the way. Reviewed by iMedic's medical editorial team.
When Does Physical Aging Really Begin? 50-Year Fitness

A landmark study tracking human fitness for nearly 50 years reveals when cardiorespiratory decline accelerates and what it means for healthy aging.
WHO Reports 60+ Countries Now Include Refugees

WHO data reveals over 60 countries now include refugees and migrants in national health policies, marking a major shift in global health equity.
Major Stem Cell Heart Failure Trial Retracted

The BMJ retracts the PREVENT-TAHA8 phase 3 trial on mesenchymal stem cells for heart failure after myocardial infarction.
FDA Approves Boehringer Ingelheim Lung Cancer Drug

The US FDA has approved first-line use of Boehringer Ingelheim's lung cancer therapy for NSCLC, expanding treatment options for newly diagnosed patients.
Hara Hachi Bu: How the Japanese 80% Rule

Hara hachi bu, the Okinawan practice of eating until 80% full, is linked to longevity and reduced chronic disease. Reviewed by iMedic's medical editorial team.
New Alzheimer's Drug Shows Promise in Boosting Brain

A newly identified Alzheimer's drug candidate enhances neuroprotection and restores memory function in preclinical models, offering fresh hope for dementia
Theranostics in Pediatric Cancer

University of Kansas Health System, Children's Mercy, and BAMF Health partner to build a fully integrated theranostic center for advanced cancer diagnosis and
Breakthrough Blood Pressure Treatment Shows Promise

Scientists reveal a new blood pressure treatment approach that works when standard medications fail, offering hope for resistant hypertension patients.
Stroke Prevention During Pregnancy

New guidance on stroke prevention and treatment during pregnancy and postpartum. Learn about risk factors, warning signs, and evidence-based strategies.
Super Large Bore Catheters for Stroke

A new systematic review examines how super large bore aspiration catheters are improving mechanical thrombectomy outcomes in acute ischemic stroke treatment.
NIH Discovers Pain-Relieving Drug With Minimal Addictive

NIH researchers identify a novel pain-relieving compound with significantly reduced addiction potential, offering hope for safer alternatives to opioids.
Vertex Wins Broader FDA Labels for Cystic Fibrosis Drugs

FDA expands labels for Vertex cystic fibrosis drugs Alyftrek and Trikafta, broadening access for more CF patients. Reviewed by iMedic's medical editorial team.
FDA Approves Eli Lilly's Orforglipron

FDA approves Eli Lilly's orforglipron, the first oral GLP-1 weight-loss pill, challenging Novo Nordisk's injectable dominance in the obesity market.
Rina-S Receives FDA Breakthrough Therapy Designation

FDA grants Breakthrough Therapy Designation to Rina-S (rinatabart sesutecan) for advanced endometrial cancer, signaling a potential new treatment option.
Common Prescription Drugs Linked to Higher C. difficile

A large Swedish study identifies commonly prescribed drugs beyond antibiotics that increase Clostridioides difficile infection risk, including PPIs and certain
FDA Regulatory Shifts in

FDA faces major regulatory shifts in 2026 affecting drug approvals, accelerated pathways, and patient access. What the changes mean for pharmaceuticals.
Knee Braces, Hydrotherapy and Exercise Outperform Drugs

A large meta-analysis of nearly 10,000 patients finds non-drug therapies like knee braces, hydrotherapy, and exercise significantly relieve knee osteoarthritis
Colorectal Cancer Research Breakthroughs

New colorectal cancer research targets molecular drivers of early-onset disease as cases in adults under 50 continue rising.
Neuroinflammation Targets Drive

New Alzheimer's drugs targeting neuroinflammation and microglial activation show promise in clinical trials, expanding treatment beyond amyloid-focused
Combination Therapy for Recurrent Prostate Cancer

New combination therapy data shows reduced death risk in recurrent prostate cancer. Learn about the treatment approach, clinical evidence, and what it means for
Next-Generation Cancer Drug Shows Surprising Anti-Aging

A next-generation cancer drug demonstrates unexpected anti-aging effects in new research, opening doors to dual-purpose therapeutics targeting both cancer and
FDA Approves Johnson & Johnson Blood Cancer Drug

FDA grants accelerated approval to new Johnson & Johnson blood cancer therapy after priority review, expanding treatment options for patients with relapsed
Deep Sleep Triggers a Powerful Growth Hormone System

Scientists discover how deep sleep activates a brain-driven growth hormone system that fuels muscle repair, fat metabolism, and cognitive performance.
FDA Approves First-of-Its-Kind Device

The FDA has approved a groundbreaking first-of-its-kind device for treating locally advanced pancreatic cancer in adults, offering new hope for patients.
FDA Approves Awiqli: First Once-Weekly Insulin

FDA approves Novo Nordisk's Awiqli (insulin icodec), the first once-weekly basal insulin injection for type 2 diabetes, reducing injections from 365 to 52 per
Gut Microbe Molecule Reduces Inflammation

Scientists discover a gut microbe-derived molecule that reduces inflammation and improves blood sugar control, opening new avenues for diabetes and metabolic
Gut Microbiota Differs in Children With Rare Food

New research from Umeå University finds children with FPIES have distinct gut microbiota patterns compared to healthy peers, opening doors for diagnosis and
Insulin Skin Cream: Could Transdermal Delivery Replace

Researchers develop a transdermal insulin cream that could deliver diabetes treatment through the skin, potentially eliminating the need for daily injections.
AI-Powered Point-of-Care Ultrasound

Butterfly Network receives FDA clearance for an AI-driven handheld ultrasound tool for pregnancy assessment, expanding prenatal care access.
Immune System and Brain Aging

New research links immune system dysfunction to brain aging, revealing potential drug targets for Alzheimer's and other neurodegenerative diseases.
New Alzheimer's Drug Stalls Disease Progression

A new experimental drug has shown remarkable ability to slow Alzheimer's disease progression in a breakthrough clinical trial, offering fresh hope for millions
How Antibiotics Reshape Your Gut Microbiome

A large-scale Nature Medicine study of nearly 15,000 individuals links individual antibiotic prescriptions to specific gut microbiome changes, with implications
Sleep vs Exercise: Which Matters More for Your Health

Should you sacrifice sleep to exercise or skip the gym to rest? New insights reveal how to balance sleep and exercise for optimal health outcomes.
Hormone Replacement Therapy for Menopause

New evidence clarifies hormone therapy's role in managing hot flashes, mood changes, and sleep disruption during menopause. What women should know in 2026.
Workplace Exercise Programs Can Significantly Reduce

A new study shows that incorporating exercise into the workday can meaningfully lower risks of chronic diseases including heart disease, diabetes, and obesity.
FDA Clears AI-Powered Ultrasound Tool

Butterfly Network receives FDA clearance for an AI-driven handheld ultrasound tool designed to assist with pregnancy assessments, expanding point-of-care
Large Study Finds No Link Between mRNA COVID-19 Vaccine

A major study tracking over 400 toddlers finds no association between mRNA COVID-19 vaccination during pregnancy and autism or developmental delays.
Alzheimer's Drug Pipeline Reaches Historic Milestone

The Alzheimer's drug pipeline has reached an unprecedented level of innovation, with multiple disease-modifying therapies now approved or in late-stage trials.
Vivid Dreams May Improve Sleep Quality

New research suggests vivid, immersive dreaming may enhance perceived sleep quality and restfulness, even when brain activity remains high during REM sleep.
MIND Diet Linked to Slower Brain Shrinkage

New research from the Framingham Heart Study shows the MIND diet may slow age-related brain shrinkage over 10 years, supporting its role in dementia prevention.
Deep Sleep Switch Discovery: How Your Brain Builds

Scientists discover a brain-driven sleep switch that activates growth hormone release during deep sleep, fueling muscle repair, fat metabolism, and cognitive
Evolocumab Cuts Heart Attack Risk by 31%

New research shows evolocumab, a powerful PCSK9 inhibitor cholesterol drug, reduces heart attack risk by 31% — potentially expanding use beyond secondary
Ozempic Linked to Lower Depression, Anxiety

New large-scale research finds GLP-1 drugs like semaglutide (Ozempic) may significantly reduce depression, anxiety, and substance use disorders beyond weight
How a Few Bad Nights Become Chronic Insomnia

Discover how occasional poor sleep spirals into chronic insomnia, what happens in the brain, and evidence-based strategies to break the cycle.
Non-Drug Treatments for Knee Osteoarthritis

Major analysis of nearly 10,000 patients finds non-drug therapies like exercise, knee braces, and hydrotherapy provide significant knee osteoarthritis pain
Sublingual Aspirin for Heart Attacks

New sublingual aspirin formulation delivers faster antiplatelet action during suspected heart attacks, with clinical trial results showing significant
Small Increases in Physical Activity

New research from Harvard highlights how even modest increases in daily physical activity can meaningfully extend lifespan, offering hope for sedentary adults.
Popular Anti-Aging Supplement NAD+ Precursors Linked

New research reveals popular NAD+ precursor supplements used for anti-aging may potentially fuel cancer cell growth.
Breakthrough Cancer Drug Shrinks Deadly Brain Tumor

A new targeted cancer drug showed rapid brain tumor shrinkage within just 5 days in early clinical results, raising hope for glioblastoma patients with limited
Child Mortality Progress Stalls

WHO reports 4.9 million children died before age five in 2024, including 2.3 million newborns. Progress in reducing child mortality is slowing globally.
Mounjaro (Tirzepatide) Now FDA-Approved

The FDA's expanded approval of tirzepatide for HFpEF in patients with obesity represents the first incretin-based therapy to receive a heart failure indication
CGM in Prediabetes Prevention Trials

Randomized controlled trials in 2026 explore whether continuous glucose monitors drive lasting behavioral change in prediabetes populations, with emerging data
Respiratory Infections in Children Under 5 Tripled

CDC reports respiratory hospitalizations in children under 5 have increased significantly as immunity gaps from reduced pathogen exposure continue to impact
AI ECG Screening Detects Atrial Fibrillation 5 Years

AI-powered electrocardiogram analysis can flag atrial fibrillation risk up to five years before clinical diagnosis, shifting cardiology toward predictive
Kresladi Gene Therapy for Severe LAD-I

Kresladi (marnetegragene autotemcel) offers a new treatment path for children with severe Leukocyte Adhesion Deficiency Type I, replacing defective ITGB2 gene
VESALIUS-CV Diabetes Results

VESALIUS-CV substudy findings show evolocumab prevents initial heart attacks and strokes in type 2 diabetes patients without prior cardiovascular disease
Cannabis for Mental Health: Landmark 2026 Review

A 2026 systematic review spanning over 100 clinical trials concludes that cannabis-based treatments lack reliable efficacy for anxiety, depression, and PTSD
Lecanemab's Fc Region Unlocks Microglial Plaque Removal

New research in 2026 shows lecanemab depends on its Fc antibody region to recruit microglia for amyloid clearance, reshaping how scientists approach Alzheimer's
Wegovy 7.2 mg FDA Approval: What the Higher Dose

The FDA approval of Wegovy 7.2 mg expands semaglutide dosing options for obesity, raising questions about patient selection, real-world adherence, and how
Alzheimer's Death Switch: How a Toxic Protein Pair

Scientists identify a destructive protein duo that forms only in tau-compromised neurons, triggering an irreversible death program — a finding that could
Antigenic Drift and the 2026–2027 Flu Vaccine

A detailed look at how antigenic drift in circulating influenza viruses prompted WHO to update both A-strain components for the 2026–2027 northern hemisphere
The Invisible Crisis: Why New Dads Hit a Mental Health

Emerging evidence shows hormonal shifts and cumulative sleep loss drive a delayed depression spike in fathers around their child's first birthday, yet most go
Cancer Drug Resistance Through Lysosome Trapping

Emerging evidence shows cancer cells exploit lysosomal pH gradients to sequester chemotherapy drugs, driving treatment failure.
Beyond Blood Sugar: Emerging Evidence

Large-scale real-world analyses and preclinical findings in 2026 suggest semaglutide may reduce addiction risk, depressive episodes, and anxiety severity
Tumor Treating Fields for Pancreatic Cancer

An in-depth look at tumor treating fields (TTFields), the alternating electric field technology behind the first FDA-approved device for locally advanced
Why Your Brain May Be Sabotaging Your Balance After 60

Scientists find balance problems in aging and Parkinson's result from brain and muscle overactivity, not weakness — opening new treatment approaches.
FDA Warns 30 Telehealth Companies and Targets Compounded

The FDA issues 30 warning letters to telehealth companies and announces steps to restrict non-approved compounded GLP-1 drugs amid safety concerns.
ADHD Brains Show Sleep-Like Activity While Awake

Researchers discover that ADHD brains experience brief episodes of sleep-like neural activity during wakefulness, potentially explaining inattention and focus
Antigenic Drift and the 2026–2027 Flu Vaccine: Inside the Science

A detailed look at how antigenic drift in circulating influenza viruses prompted WHO to update both A-strain components for the 2026–2027 northern hemisphere
Erythritol and Brain Vascular Injury

A 2026 study links erythritol consumption to cerebrovascular endothelial harm and blood-brain barrier disruption, adding urgency to ongoing safety debates about
Mezigdomide (Opzykio) FDA Approval

Mezigdomide receives FDA accelerated approval for relapsed or refractory multiple myeloma, offering a cereblon E3 ligase modulator option for patients who have
Artificial Sweeteners Disrupt Gut Microbiome

Growing evidence from clinical trials and cohort studies links daily artificial sweetener use to higher glucose intolerance risk via gut microbiome disruption.
Childhood Asthma Hospitalizations Surge Up

A decade of environmental health data shows wildfire smoke episodes drive dramatic spikes in pediatric asthma hospitalizations, with fine particulate matter
Deep Brain Stimulation in Early Parkinson's Disease

Growing clinical evidence suggests that deep brain stimulation applied in early Parkinson's disease may significantly slow motor progression compared to
Abrysvo Real-World Evidence

First post-licensure effectiveness data from the 2025-2026 RSV season confirm that prenatal Abrysvo vaccination prevents approximately 82 percent of severe RSV
Zanzalintinib: How Exelixis Built a Smarter Cabozantinib

Zanzalintinib (XL092) represents a structure-guided redesign of cabozantinib targeting VEGFR, MET, and TAM kinases with improved selectivity.
FDA Approves Alhemo (Fitusiran) for Hemophilia A and B

FDA approves fitusiran (Alhemo) as first once-monthly subcutaneous treatment for hemophilia A and B with or without inhibitors.
Workplace Burnout Doubles Cardiovascular Event Risk

Growing evidence from large prospective studies indicates chronic workplace burnout substantially increases the risk of heart attack and stroke, independent of
Maternal COVID-19 Infection Linked to 38% Higher Autism

Growing body of research, including large Nordic and North American cohort studies, finds maternal COVID-19 infection during pregnancy may be associated with
PREDIMED-2 Trial 2026: How a Mediterranean Diet Cut

The PREDIMED-Plus (PREDIMED-2) trial demonstrates that combining a Mediterranean diet with lifestyle interventions reduces cardiovascular events by 28% in
Measles Outbreaks Surge 300% Globally

WHO reports a dramatic increase in global measles cases in early 2026, with dozens of countries experiencing active outbreaks fueled by declining vaccination
Living Within 200 Meters of Major Roads Increases

Research involving large European birth cohorts finds that living within 200 meters of major roads significantly increases childhood asthma risk, with
Zorifertinib Achieves 67% Intracranial Response

Zorifertinib (AZD3759), a brain-penetrating EGFR inhibitor, demonstrated superior intracranial activity in EGFR-mutant NSCLC with brain metastases in the Phase
Retatrutide Triple Agonist Achieves 24 Percent Weight

Retatrutide's unprecedented 24.2% body weight reduction in Phase 2 trials positions this GLP-1/GIP/glucagon triple agonist as a potential breakthrough for type
Ecnoglutide EMERGE Trial: Dual GI Peptide Approach

The Phase 2 EMERGE trial of ecnoglutide (XW004) demonstrates that targeting dual gastrointestinal peptide pathways may offer a differentiated obesity treatment
Teplizumab Delays Type 1 Diabetes Onset by 4 Years

Extended follow-up of the TN-10 teplizumab trial suggests the immunotherapy may delay type 1 diabetes onset by several years in high-risk children, building on
Efruxifermin FGF21 Analog Reverses Liver Fibrosis

Efruxifermin Phase 3 HARMONY trial reports significant fibrosis improvement in MASH patients with cirrhosis. Reviewed by iMedic's medical editorial team.
Statin Therapy and Dementia Risk

Decades of large cohort studies tracking millions of adults reveal that sustained statin therapy is linked to roughly 30% lower dementia incidence, with
Toripalimab Plus Chemotherapy Extends Survival

The JUPITER-06 Phase 3 trial showed that toripalimab combined with chemotherapy significantly extends overall survival in PD-L1-positive advanced gastric cancer
Imetelstat (Rytelo) FDA Approval

FDA-approved imetelstat (Rytelo) for transfusion-dependent lower-risk MDS achieves 40% red blood cell transfusion independence in pivotal Phase 3 trial.
Rezafungin (Rezzayo): How the First Weekly-Dosed IV

Rezafungin's unique 130-hour half-life enables once-weekly IV dosing for invasive candidiasis, offering hospitals a practical path to outpatient antifungal
Nationwide Registry Data Reveal Trimester-Specific Link

Analysis of Swedish registry data covering half a million births identifies a critical gestational window in which untreated maternal iron deficiency anemia
Mediterranean Diet Reduces Dementia Risk by 40%

Large-scale prospective studies find that strict Mediterranean diet adherence may reduce dementia risk by up to 23-40%, regardless of genetic predisposition.
mRNA Vaccine Against Epstein-Barr Virus Shows 78%

Moderna's mRNA vaccine targeting Epstein-Barr virus reports promising neutralizing antibody responses in early-phase trials, offering hope for MS prevention.
Social Prescribing Reduces Anxiety

Growing evidence from NHS-funded research suggests structured community activities can meaningfully reduce anxiety and depression in primary care patients
FDA Approves Solzaritinib for EGFR Exon 20 Lung Cancer

FDA grants full approval to solzaritinib for EGFR exon 20 insertion-mutated non-small cell lung cancer, demonstrating a strong objective response rate in
Maridebart Cafraglutide Dual Myostatin-GLP-1 Therapy

A dual myostatin inhibitor and GLP-1 combination therapy aims to preserve lean muscle mass while achieving significant weight loss, addressing a key limitation
Air Pollution Exposure Triples Dementia Risk

Large-scale research finds PM2.5 air pollution substantially increases dementia risk in low-income areas, revealing stark environmental health disparities tied
mRNA-1403 Phase 2 Results: How Moderna's Norovirus

Phase 2 trial data for Moderna's mRNA-1403 norovirus vaccine reveal strong immune responses targeting multiple genotypes, offering hope against a pathogen that
Roxadustat HIF-PHI Oral Anemia Drug Shows Superior

Long-term follow-up data show roxadustat, an oral HIF-PHI drug, maintains hemoglobin levels with reduced need for blood transfusions and iron supplementation
Pirtobrutinib (Jaypirca) Gains First-Line CLL

Pirtobrutinib's expanded first-line CLL approval marks a shift toward reversible BTK inhibition in hematology, with the BRUIN-CLL-321 trial demonstrating
Childhood Antibiotic Overuse Doubles Risk

Growing body of research finds that multiple antibiotic courses before age 2 substantially increase the risk of asthma and inflammatory bowel disease by age 10
Maternal Obesity Linked to Epigenetic Changes

Growing evidence shows maternal obesity causes epigenetic modifications in offspring DNA, increasing cardiovascular disease risk substantially into adulthood.
Sotagliflozin (Inpefa) Label Expansion

Sotagliflozin's 2026 FDA label expansion for HFpEF in type 2 diabetes patients marks a milestone in cardiometabolic medicine, leveraging its unique
Night Shift Work Increases Type 2 Diabetes Risk by 44%

Multiple meta-analyses confirm that long-term night shift workers face a significantly higher risk of type 2 diabetes, with circadian disruption identified as a
Ketamine Nasal Spray Achieves 67% PTSD Remission

Growing clinical trial evidence suggests intranasal ketamine may achieve high PTSD remission rates in treatment-resistant veterans.
Mediterranean Diet School Program Reduces Childhood

A multi-year school-based Mediterranean diet program across several countries significantly reduced childhood obesity and improved metabolic markers, according
Lecanemab Subcutaneous Autoinjector FDA Approval

A detailed look at the FDA's clearance of the lecanemab subcutaneous autoinjector for early Alzheimer's disease, examining the pharmacokinetic rationale
8-Year Follow-Up Confirms Teplizumab's Durable

Eight years of follow-up from the TrialNet TN-10 trial reveal that teplizumab's protective effect against Type 1 diabetes persists far longer than initially
Danuglipron Twice-Daily Oral GLP-1 Pill Delivers 17

Clinical trial data show Pfizer's twice-daily oral GLP-1 pill danuglipron achieves roughly 17 percent body weight reduction, raising questions about how dosing
No Safe Level of Lead: CDC Lowers Childhood Blood Lead

CDC lowers blood lead reference value to 2.5 μg/dL as accumulating research shows measurable IQ loss even at levels previously considered safe, reinforcing that
FDA Approves First Triple-Combination Diabetes Pill

The FDA has approved a fixed-dose triple-combination pill combining metformin, an SGLT2 inhibitor, and a DPP-4 inhibitor for type 2 diabetes, aiming to
FDA Approves Ciltacabtagene Autoleucel (Carvykti)

FDA expanded Carvykti approval to second-line multiple myeloma based on CARTITUDE-4 data showing significant progression-free survival benefit, making it the
FDA Approves Mirdametinib for NF1 Plexiform

FDA approved mirdametinib (Ojemda) as a MEK inhibitor for inoperable plexiform neurofibromas in NF1 patients aged 2+, with meaningful tumor shrinkage
First Effective Group A Strep Vaccine Enters Phase 3

A leading Group A Streptococcus vaccine candidate has entered Phase 3 clinical trials after showing promising efficacy against pharyngitis in children in Phase
Universal Maternal Depression Screening Improves Infant

Growing evidence from NIH-supported research shows that universal perinatal depression screening combined with integrated treatment can significantly improve
Gut Microbiome and Immunotherapy Response

Research reveals how specific gut bacterial metabolites modulate T-cell function and influence checkpoint inhibitor efficacy in cancer patients, opening new
Ketamine Nasal Spray Reduces Suicidal Ideation

Growing real-world evidence confirms intranasal esketamine rapidly reduces acute suicidal ideation within hours, supporting expanded emergency department use
Large Cohort Data Reveals Accelerated Brain Aging

Large-scale cohort studies tracking adults exposed to lead in childhood show measurable brain aging acceleration, with structural MRI findings and cognitive
Ultra-Processed Food Linked to 12 Cancer Types

Growing body of meta-analytic evidence finds ultra-processed food consumption increases risk for multiple cancer types by up to 30%.
Ketamine for Treatment-Resistant Depression

Growing long-term evidence on ketamine therapy confirms sustained antidepressant effects with no significant cognitive deterioration, reshaping
Iptacopan Oral Complement Inhibitor Shows 72% Hemoglobin

Novartis's iptacopan (Fabhalta), the first oral complement factor B inhibitor, demonstrates significant hemoglobin gains in PNH and meaningful proteinuria
Universal Newborn Whole Genome Screening Pilot

Pilot programs in the UK and US are screening tens of thousands of newborns with whole genome sequencing, aiming to detect hundreds of treatable genetic
Can a Mediterranean Diet Cut Colorectal Cancer

Nutritional oncology trials and pooled analyses increasingly link Mediterranean dietary patterns to meaningful reductions in colorectal cancer recurrence, with
FDA Approves Iptacopan for IgA Nephropathy

FDA approves iptacopan (Fabhalta) for IgA nephropathy, the first oral complement factor B inhibitor shown to significantly reduce proteinuria in the
SELECT Trial Final Results: How Semaglutide's 20% MACE

Final SELECT trial data detail how weekly semaglutide 2.4 mg cut major cardiovascular events by one-fifth in adults with obesity and pre-existing heart disease
Newborn Screening for Spinal Muscular Atrophy Leads

Growing evidence from multiple clinical trials shows over 90% of SMA infants identified through newborn screening and treated with gene therapy before symptoms
Imeglimin Plus Metformin Combination Reduces

Emerging evidence suggests imeglimin plus metformin combination may reduce cardiovascular risk in type 2 diabetes patients, building on promising Phase 3
Donanemab Plus BACE Inhibitor Combination Achieves 82%

Researchers are exploring whether combining donanemab with a low-dose BACE inhibitor could enhance amyloid plaque clearance and further slow cognitive decline
Blood Biomarker Panel Detects Postpartum Psychosis Risk

Researchers are developing blood biomarker panels that may predict postpartum psychosis risk during pregnancy, enabling early intervention for this rare but
Oral Semaglutide 50mg and the OASIS Program

High-dose oral semaglutide at 50mg achieved roughly 15 percent weight loss in the OASIS 1 trial, while the OASIS 4 study of the 25mg dose led to the first
Ultra-Processed Food Linked to Accelerated Brain Aging

Large-scale prospective studies involving tens of thousands of adults find ultra-processed food consumption significantly accelerates cognitive decline.
Exercise Snacking: 10-Minute Activity Bouts Cut

Research using UK Biobank accelerometer data shows that accumulating physical activity through short 10-minute bouts throughout the day can substantially reduce
New Blood Test Detects Postpartum Depression

A novel blood biomarker panel shows promise for detecting postpartum depression risk weeks before symptoms appear. Reviewed by iMedic's medical editorial team.
Amycretin Phase 2 Results: How a Dual-Hormone Oral Pill

Novo Nordisk's oral amycretin combined amylin and GLP-1 receptor activation in a single tablet, delivering up to 25% body weight reduction in Phase 2 trials —
Crovalimab Monthly Subcutaneous Injection Approved

Crovalimab (Piasky), a once-monthly self-injectable complement C5 inhibitor, demonstrates effective hemolysis control in paroxysmal nocturnal hemoglobinuria
FDA Expands Eplontersen (Wainua)

Eplontersen receives FDA approval for hereditary transthyretin amyloid cardiomyopathy, offering patients a once-monthly self-injectable antisense therapy that
CAR-T Cell Therapy for Solid Tumors

Emerging CAR-T cell therapy trials targeting mesothelin in pancreatic cancer are showing encouraging early response rates, marking a potential breakthrough for
Invasive Group A Strep Infections in Children Surge 40%

Health authorities report a significant rise in invasive Group A Strep infections among children. Reviewed by iMedic's medical editorial team.
Wildfire Smoke Exposure and Cardiovascular Events

Research reveals that inhaling wildfire smoke PM2.5 can double the likelihood of heart attack or stroke within 48 hours, with vulnerable populations facing even
Survodutide in MASH: Can Dual Glucagon/GLP-1 Agonism

Survodutide leverages simultaneous glucagon and GLP-1 receptor engagement to clear hepatic fat and reduce fibrosis in MASH, with Phase 3 results expected to
Zolbetuximab (Vyloy): How Astellas' Claudin 18.2

Astellas Pharma's zolbetuximab (Vyloy) marks a paradigm shift in gastric cancer care as the first therapy targeting claudin 18.2, opening a new biomarker-driven
Meta-Analysis of 2.8 Million Patients Finds Up

A large-scale meta-analysis pooling data from 2.8 million participants across dozens of studies reports that long-term lipophilic statin users may experience
Imeglimin (Twymeeg) and Mitochondrial Dysfunction

Imeglimin (Twymeeg) is the first glimide-class drug designed to correct mitochondrial respiratory dysfunction in type 2 diabetes, addressing impaired cellular
Tirzepatide for HFpEF: FDA Approval Pathway, Prescribing

A detailed look at the FDA's decision to approve tirzepatide for HFpEF with obesity, the regulatory evidence package behind the label, real-world prescribing
Bempedoic Acid Long-Term Safety

Long-term follow-up data confirm bempedoic acid (Nexletol) provides sustained cardiovascular risk reduction in statin-intolerant patients, building on the
Tirzepatide for MASH Liver Disease

FDA approves tirzepatide for MASH liver disease treatment, building on phase 2 SYNERGY-NASH trial results showing significant MASH resolution rates.
Statin Muscle Pain Largely Due to Nocebo Effect

A growing body of rigorous clinical evidence confirms that the majority of statin-related muscle symptoms are attributable to the nocebo effect, not the
Childhood Lead Exposure Causes 765 Million IQ Points

UNICEF and Pure Earth data show childhood lead exposure causes hundreds of millions of IQ points lost annually worldwide, with low- and middle-income countries
Keytruda Quadruples 5-Year Cure Rate

Long-term KEYNOTE-522 data shows adding pembrolizumab to chemotherapy significantly improves pathological complete response rates and event-free survival in
Gepirone ER Finally Approved

The FDA approved gepirone ER (Exxua), the first 5-HT1A agonist antidepressant, offering a favorable side-effect profile with minimal sexual dysfunction — the
Milvexian: Next-Generation Blood Thinner

The factor XIa inhibitor milvexian is being evaluated in the Phase 3 LIBREXIA-AF trial to determine whether it can prevent stroke in atrial fibrillation
Jardiance (Empagliflozin) Shows Unexpected Benefit

Growing clinical evidence suggests empagliflozin significantly reduces liver fat and improves metabolic markers in patients with metabolic
Prostate Cancer Active Surveillance Safe After 15 Years

15-year ProtecT trial results confirm active surveillance is safe for low-risk prostate cancer, with approximately 97% cancer-specific survival and
Cold Water Immersion After Exercise

Research confirms cold water immersion reduces post-exercise inflammation and soreness but may blunt muscle hypertrophy gains from resistance training.
Untreated Hearing Loss Now Top Modifiable Dementia Risk

The Lancet Dementia Commission identifies untreated hearing loss as the single largest modifiable risk factor for dementia, with emerging evidence that hearing
Calorie Restriction vs Exercise for Weight Loss

Research shows exercise-based weight loss preserves resting metabolic rate significantly better than calorie restriction alone, challenging traditional
Tirzepatide (Mounjaro) Shows Kidney Protective Effects

Emerging analyses of tirzepatide clinical trial data suggest the dual GIP/GLP-1 receptor agonist may significantly slow kidney function decline in patients with
Atogepant (Qulipta) 3-Year Safety Data Confirms

Long-term open-label extension data for oral CGRP antagonist atogepant shows sustained migraine reduction with no new safety signals in chronic and episodic
Zoliflodacin: First New Antibiotic Class

FDA approves zoliflodacin, a first-in-class spiropyrimidinetrione antibiotic for uncomplicated gonorrhea, offering a new weapon against drug-resistant
Hidden Heart Valve Disease: How AI-Enhanced ECG Analysis

AI-driven ECG interpretation identifies subclinical aortic stenosis before symptoms emerge, offering a low-cost screening pathway that could transform valve
WHO Report: Global Sodium Reduction Could Save 7 Million

WHO data shows implementing sodium reduction policies worldwide could prevent millions of cardiovascular deaths by 2030, with simple reformulation of processed
Standing Desks Reduce Cardiovascular Risk

Growing evidence from workplace intervention trials shows that alternating between standing and sitting at work can meaningfully reduce cardiovascular disease
Lenacapavir Twice-Yearly Injection Achieves 96% Efficacy

Lenacapavir twice-yearly injection demonstrates up to 100% efficacy for HIV PrEP in PURPOSE trials enrolling over 8,600 participants, establishing the first
Asundexian Phase 3 OCEANIC-STROKE Trial

Factor XIa inhibitors like asundexian represent a promising but unproven approach to stroke prevention in atrial fibrillation, aiming to uncouple antithrombotic
Deucravacitinib (Sotyktu) 3-Year POETYK Extension Data

Long-term POETYK extension data indicate deucravacitinib sustains PASI 75 response in approximately two-thirds of patients through three years, with no
FDA Approves First Fixed-Dose CGRP Combination

A fixed-dose oral combination of rimegepant and atogepant for migraine prevention reportedly achieves significantly greater reductions in monthly migraine days
HIIT 3 Times Weekly Reverses Prediabetes

A growing body of RCTs and meta-analyses show HIIT 3x/week can substantially improve prediabetes markers, with some studies reporting reversal rates nearly
Social Media Use Over 3 Hours Daily Linked

Research published in JAMA Psychiatry and other leading journals finds that teens using social media more than 3 hours daily face roughly double the risk of
Probiotics Reduce Anxiety Symptoms by 31%

Growing evidence from multiple meta-analyses finds specific probiotic strains can meaningfully reduce anxiety symptoms via the gut-brain axis, with multi-strain
PM2.5 Air Pollution Increases Childhood Asthma Risk

Growing evidence from large-scale global research links PM2.5 exposure to substantially increased childhood asthma risk, even below current WHO guidelines.
Movement Breaks Every 30 Minutes Cut All-Cause Mortality

Large-scale research from the PROGRESS consortium suggests frequent movement breaks during prolonged sitting substantially reduce all-cause mortality, with
Resmetirom (Rezdiffra) One-Year Outcomes

The MAESTRO-NASH Phase 3 trial demonstrated that resmetirom (Rezdiffra) achieved approximately 50% liver fat reduction and MASH resolution in about 30% of
Duvakitug Anti-TL1A Antibody Shows 47% Endoscopic

Duvakitug, a first-in-class anti-TL1A antibody developed by Teva and Sanofi, achieved approximately 48% endoscopic response in moderate-to-severe Crohn's
MK-0616: First Oral PCSK9 Inhibitor Achieves 60% LDL

MK-0616, the first oral PCSK9 inhibitor by Merck, achieves approximately 60% LDL-C reduction in Phase 3 trials, matching injectable evolocumab and alirocumab
Donanemab Real-World Data: 8,500-Patient Analysis

Emerging real-world evidence on donanemab (Kisunla) is consistent with Phase 3 TRAILBLAZER-ALZ 2 trial findings, which showed approximately 35% slowing of
FDA Approves Bimekizumab (Bimzelx)

The FDA expands bimekizumab (Bimzelx) approval to psoriatic arthritis based on BE COMPLETE Phase 3 data showing ACR50 response of approximately 44% vs 7%
Irregular Sleep Patterns Increase Cardiovascular Disease

Analysis of MESA Sleep Ancillary Study data shows adults with irregular sleep timing have approximately 27% higher CVD risk and significantly higher heart
WHO Updates Childhood Obesity Prevention Guidelines

WHO raises physical activity recommendation from 60 to 90 minutes daily for children 5-17 as global childhood obesity reaches unprecedented levels, with
Digital CBT Apps Now Match In-Person Therapy

A large-scale non-inferiority trial suggests AI-guided digital CBT achieves PHQ-9 improvement comparable to face-to-face therapy for mild-to-moderate
Mediterranean Diet Combined with Time-Restricted Eating

Emerging clinical evidence suggests that combining a Mediterranean diet with a 10-hour eating window may achieve substantially greater long-term weight loss
Psilocybin-Assisted Therapy Receives FDA Priority Review

COMPASS Pathways advances COMP360 psilocybin therapy toward FDA review for treatment-resistant depression, building on Phase 2b data showing approximately 29%
Hemophilia B Gene Therapy Shows Durable Response

Long-term follow-up of etranacogene dezaparvovec (Hemgenix) gene therapy confirms sustained factor IX expression well above therapeutic thresholds, maintaining
Abelacimab: New Anticoagulant Prevents Blood Clots

Clinical trial results show abelacimab, a factor XI inhibitor, reduces stroke risk in atrial fibrillation with approximately 67% less major bleeding than
FDA Approves Ritlecitinib: First Oral JAK Inhibitor

The FDA approves ritlecitinib (Litfulo) as the first oral treatment for non-segmental vitiligo, with Phase 3 trials showing significant facial repigmentation in
Tirzepatide Outperforms Semaglutide

Indirect comparisons from major clinical trials suggest tirzepatide (Zepbound) achieves approximately 22–23% weight loss versus semaglutide's (Wegovy)
Childhood Screen Time Over 3 Hours Daily Doubles ADHD

Growing evidence from multiple longitudinal studies suggests that screen time exceeding 3 hours daily before age 5 may substantially increase the risk of ADHD
7 Hours of Sleep Is the Sweet Spot for Brain Health

Research from the University of Cambridge, analyzing approximately 500,000 UK Biobank participants, found that 7 hours of sleep is optimal for cognitive
Vitamin D Deficiency Linked to 40% Higher Risk

A growing body of large-scale research, including prospective cohort studies and the landmark VITAL trial, indicates that chronic vitamin D deficiency
Blood Pressure Below 120 Prevents 30% of Strokes

Growing evidence supports systolic BP targets below 120 mmHg, with research indicating approximately 25% fewer major cardiovascular events and significant
GLP-1 Weight Loss Medications

Complete guide to GLP-1 weight loss drugs in 2026. Semaglutide, tirzepatide efficacy, side effects, costs. Reviewed by iMedic's medical editorial team.
Dupilumab Becomes First Biologic Approved for COPD

Dupilumab (Dupixent) is the first biologic therapy approved for COPD with type 2 inflammation, reducing exacerbations by approximately 30% in the landmark
New Antibiotic Zosurabalpin Kills Drug-Resistant

Roche's zosurabalpin uses a completely new antibiotic mechanism targeting lipopolysaccharide transport and has shown potent activity against
Semaglutide Reduces Chronic Kidney Disease Progression

The FLOW trial confirms semaglutide 1mg reduces major kidney events by 24% in patients with type 2 diabetes and chronic kidney disease, establishing GLP-1 drugs
Icodec: Revolutionary Once-Weekly Insulin Approved

The FDA approves insulin icodec (Awiqli), the first once-weekly basal insulin, showing equivalent glucose control to daily insulin with 83% fewer injections per
Metformin Shows Anti-Aging Benefits

The landmark TAME trial has reported that metformin significantly reduces the composite incidence of age-related diseases, supporting the hypothesis that a
Atogepant Extended-Release Gains FDA Clearance

The FDA's approval of extended-release atogepant (Qulipta ER) for chronic migraine prevention introduces improved pharmacokinetics and steadier CGRP blockade
New Weight Loss Study: GLP-1 Drugs Combined

Research shows combining GLP-1 medications like semaglutide with intensive behavioral therapy can significantly improve weight loss outcomes and long-term
WHO Reports Record Low Malaria Deaths

Global malaria deaths have declined significantly, driven by the rollout of RTS,S and R21 malaria vaccines to more than 20 African countries reaching millions
Personalized mRNA Vaccine Doubles Survival

BioNTech's personalized mRNA cancer vaccine autogene cevumeran shows promising results in pancreatic cancer, with Phase 2 data suggesting substantially improved
AI-Powered Retinal Scans Detect Parkinson's Disease 7

Research using AI to analyze retinal scans has identified Parkinson's disease biomarkers up to 7 years before clinical symptoms develop, based on analysis of UK
Evidence-Based Weight Loss: What Actually Works

Science-backed weight loss strategies for 2026. Evidence from clinical trials on diet, exercise, behavioral therapy and metabolic health for sustainable
Weight Loss Medications Compared

Head-to-head comparison of weight loss medications 2026. Ozempic vs Wegovy vs Mounjaro vs Zepbound. Reviewed by iMedic's medical editorial team.
FDA Clears Dual-Hormone Artificial Pancreas for Type 1

Beta Bionics' iLet Bionic Pancreas system with dual-hormone (insulin + glucagon) delivery advances toward clinical use for Type 1 diabetes.
Gene Therapy for Sickle Cell Disease

Extended follow-up of CRISPR gene therapy Casgevy shows the vast majority of sickle cell patients remain pain crisis-free beyond two years.
New Antibiotic Cresomycin Defeats All Tested Superbugs

Cresomycin, a synthetic antibiotic designed at Harvard using structural biology, showed potent preclinical activity against drug-resistant MRSA, VRE, and CRE
FDA Approves First Once-Daily Oral GLP-1 Pill

The FDA has approved orforglipron, the first non-injectable GLP-1 receptor agonist for obesity. Clinical trials showed approximately 14.7% body weight loss
New 'Exercise Pill' Mimics Benefits

Experimental compound SLU-PP-332 activates exercise-related gene pathways, significantly improving endurance and reducing body fat in mice without physical
Sleeping Less Than 5 Hours Doubles Dementia Risk

Large-scale research on sleep and dementia links chronic short sleep to significantly increased Alzheimer's risk. Reviewed by iMedic's medical editorial team.
Scientists Identify Autoimmune Mechanism

Researchers have identified autoimmune mechanisms that may drive persistent fatigue in Long COVID, including autoantibodies that interfere with normal cellular
Microplastics Found Crossing Blood-Brain Barrier

Growing research shows nanoplastics can cross the human blood-brain barrier. Studies analyzing post-mortem brain tissue reveal increasing microplastic
WHO: Global Mental Health Crisis Reaches Record Levels

WHO data shows nearly 1 billion people worldwide live with a mental health disorder. Anxiety and depression rates surged approximately 25% during and after the
Fat Cell 'Self-Combustion' Discovery

Emerging research explores how ferroptosis-related pathways involving the ACSL4 enzyme could potentially trigger fat cells to burn their own energy stores
Sleep Deprivation and Mental Health

How chronic sleep deprivation fuels anxiety, depression, and cognitive decline. Evidence-based research on sleep interventions and mental health.
CagriSema Achieves 23% Weight Loss But Falls Short

Novo Nordisk's CagriSema combination drug shows approximately 22.7% weight loss in Phase 3 REDEFINE-1 trial, below the expected 25%+ that analysts predicted
NHS Galleri Trial: Cancer Blood Test Detects 2x

The NHS-Galleri trial of 140,000 participants shows the Galleri multi-cancer blood test may substantially improve early-stage cancer detection rates.
FDA Approves Bysanti (Milsaperidone)

FDA approves Bysanti (milsaperidone), a TAAR1 agonist antipsychotic, for schizophrenia and bipolar I disorder. Reviewed by iMedic's medical editorial team.
Blood Test Predicts Alzheimer's Symptom Onset Up

New blood biomarker panel shows promise for predicting Alzheimer's disease symptom onset years before clinical diagnosis with over 90% accuracy.
Stanford Develops Universal Nasal Spray Vaccine

Stanford researchers are developing a nasal spray vaccine platform targeting COVID-19 variants, influenza strains, and pneumococcal pneumonia, building on
World's Best Hospitals 2026: Mayo Clinic Tops Newsweek

Newsweek's 2026 World's Best Hospitals ranking places Mayo Clinic first once again. Cleveland Clinic, Charité, and Singapore General Hospital are among the
Limiting Sugar Before Age 2 Cuts Heart Disease Risk

Research including a landmark Science study on early-life sugar exposure shows children who consumed minimal added sugar before age 2 had significantly lower
Study: Living Near Nuclear Plants Linked

Multiple large-scale studies have found modestly elevated cancer rates, particularly childhood leukemia, in communities near nuclear power plants.
CDC: Youth Obesity Hits Record 22.4% While Adult Rates

CDC data reveals US childhood obesity has reached record levels while adult obesity rates show first signs of plateauing.
New Insomnia Drug Class Shows Superior Safety

Dual orexin receptor antagonists (DORAs) demonstrate equivalent efficacy to benzodiazepines for insomnia with significantly lower risks of falls, cognitive
FDA Grants Breakthrough Status to Psilocybin for PTSD

FDA designates psilocybin-assisted therapy as Breakthrough Therapy for PTSD after early clinical trial data suggests a majority of participants no longer
One-Time CRISPR Injection Permanently Lowers Cholesterol

Verve Therapeutics reports CRISPR base editing injection has shown LDL cholesterol reductions of up to 55% in the ongoing HEART-1 trial.
Drug-Resistant UTIs Rising Sharply in Women Worldwide

Antibiotic-resistant urinary tract infections are rising sharply in women worldwide. E. coli resistance to first-line antibiotics now exceeds 40% in many
Intermittent Fasting Extends Lifespan

Growing body of research on intermittent fasting suggests time-restricted eating may improve cardiometabolic health markers, though long-term mortality data in
Artificial Womb Technology Shows Promise

Biobag artificial womb technology moves toward first human trials for extremely premature infants born before 28 weeks.
Gut Bacteria Linked to Parkinson's Disease Onset

Growing research confirms gut microbiome changes may precede Parkinson's motor symptoms by years. Reviewed by iMedic's medical editorial team.
WHO: 1.8 Billion Adults Physically Inactive

WHO data shows 1.8 billion adults are physically inactive worldwide, raising risk of cardiovascular disease, diabetes, and cancer.
90% of Penicillin Allergy Labels Are Wrong

Studies confirm approximately 90% of patients labeled penicillin-allergic can safely tolerate the drug. Reviewed by iMedic's medical editorial team.
Global Childhood Myopia Epidemic

Childhood myopia is rising dramatically worldwide, with projections of 50% global prevalence by 2050. Reviewed by iMedic's medical editorial team.
Social Isolation Raises Mortality Risk by 29%

US Surgeon General warns social isolation and loneliness increase mortality risk by 29% and 26% respectively. Reviewed by iMedic's medical editorial team.
New Antibiotics Against Superbugs

New antibiotics in 2026 targeting drug-resistant superbugs. AI-discovered compounds and phage therapy show promise against AMR.
New Monthly Migraine Injection Eliminates Attacks

Next-generation bispecific antibody targeting the CGRP pathway shows promising results in chronic migraine patients, with early trial data suggesting
WHO: Air Pollution Now Kills 8.1 Million People Per Year

Updated WHO data indicates air pollution is responsible for an estimated 7–8 million premature deaths annually, confirming it as the single largest
Exercise Matches or Exceeds Medication

A sweeping umbrella review of 97 systematic reviews and over 128,000 participants finds exercise consistently reduces depression and anxiety symptoms, matching
Maternal Syphilis Rate Surges 28% in Two Years

CDC data shows maternal syphilis rate increased 28% from 2022 to 2024, reaching 357.9 per 100,000 births. Reviewed by iMedic's medical editorial team.
One Stem Cell Generates 14 Million Cancer-Killing NK

Chinese scientists develop a scalable method to mass-produce natural killer cells from cord blood stem cells, potentially making cancer immunotherapy cheaper
Lab-Grown Human Spinal Cord Heals After Injury

Northwestern scientists build an advanced human spinal cord organoid model and demonstrate healing with 'dancing molecules' therapy.
Reengineered HPV Nanovaccine Trains T Cells

Northwestern researchers show that repositioning an HPV protein fragment on a DNA nanovaccine produces a dramatically stronger immune response, significantly
Exercise and Heart Disease Prevention: New Evidence for

Latest research on exercise and heart disease prevention. Updated guidelines on optimal types, duration, and intensity of physical activity.
Brain Implant Restores Natural Speech

Brain-computer interface technology for speech decoding has reached over 90% accuracy and 60+ words per minute, bringing paralyzed patients closer to real-time
COVID-19 Survivors Face Elevated Sleep Apnea Risk

Emerging research suggests COVID-19 survivors have significantly higher rates of obstructive sleep apnea diagnosis for years after infection, adding to growing
Scientists Discover Hidden Class of Cancer-Specific RNAs

Researchers uncover approximately 260,000 oncRNAs — cancer-specific RNA molecules found across 32 cancer types — with potential for liquid biopsy diagnostics
Shingles Vaccine May Protect Against Alzheimer's

Research identifies shingles vaccine, sildenafil, and riluzole as top candidates for Alzheimer's prevention. Reviewed by iMedic's medical editorial team.
mRNA Vaccine Technology Beyond COVID: Breakthroughs in

mRNA vaccines beyond COVID-19 in 2026. Cancer vaccines, flu-COVID combos, HIV, and more. Reviewed by iMedic's medical editorial team.
Women's Heart Disease: Why Sex-Specific Differences Lead

Heart disease is the #1 killer of women worldwide. Sex-specific differences in symptoms, conditions like SCAD and takotsubo, lead to underdiagnosis and worse
CDC Childhood Vaccine Changes

CDC reduced universally recommended childhood vaccines from 18 to 11 in 2026. Learn what changed, what the AAP recommends, which vaccines were reclassified, and
Dengue Fever Surges Globally

Dengue cases hit record 12.4 million in 2024 as climate change expands Aedes aegypti range. New endemic areas emerging in Europe and US.
Hepatitis C Elimination: The 95% Cure

Hepatitis C is now curable in 95%+ of cases with 8-12 week oral DAA treatment. WHO targets elimination by 2030, but approximately 50 million remain infected.
Gut Microbiome and Health: Major Breakthroughs in

Recent discoveries linking gut microbiome to immunity, mental health, and chronic disease. New precision probiotic therapies show promise.
Opioid Crisis Update: Expanding Buprenorphine Access

US opioid crisis: 81,000+ overdose deaths in 2023. X-waiver eliminated to expand buprenorphine access. Naloxone now available OTC. Harm reduction saves lives.
Blood Thinners: DOACs vs Warfarin

Blood thinner comparison 2026. DOACs vs warfarin, Factor XI inhibitors, personalized anticoagulation. Reviewed by iMedic's medical editorial team.
New Anxiety Treatments in

New anxiety treatments in 2026 include MM120 (psychedelic-derived therapy) for generalized anxiety and vagus nerve stimulation for treatment-resistant
Folic Acid Fortification: How Flour Enrichment Prevents

Folic acid fortification prevents neural tube defects like spina bifida. Over 60 countries mandate flour fortification, preventing an estimated 22,000 NTDs
Whooping Cough Resurgence: Why Pertussis Cases

Pertussis cases surged in 2024-2025, with CDC reporting highest US cases since 2014. Waning immunity from acellular vaccines drives resurgence.
Norovirus Vaccine Development

Norovirus causes 685 million cases and 200,000 deaths annually. Vaccine candidates from HilleVax and Moderna show promise but face genotype diversity
Blood Pressure Targets Debate

SPRINT trial showed intensive BP control (<120 mmHg) reduced CVD events by 25%. ACC/AHA and ESC guidelines now recommend lower targets for most adults.
Exercise as Medicine: How Physical Activity Prevents

WHO recommends 150 min moderate or 75 min vigorous exercise weekly. Physical inactivity causes 3.2 million deaths/year. Exercise reduces chronic disease risk.
Melanoma Immunotherapy: 10-Year Survival Data Shows

CheckMate 067 reveals 49% of advanced melanoma patients alive at 10 years with nivolumab plus ipilimumab, a dramatic leap from the historical 5% survival.
Romosozumab for Osteoporosis

Romosozumab (Evenity) is a dual-action anti-sclerostin antibody building bone while reducing resorption. ARCH trial shows 48% fewer vertebral fractures.
ADHD Medication Update: New Treatments

2026 ADHD medication guide. New non-stimulants, digital therapeutics, updated guidelines for adults and women. Reviewed by iMedic's medical editorial team.
Lupus Treatment Update: Belimumab, Anifrolumab

Targeted therapies transform systemic lupus erythematosus treatment. Belimumab, anifrolumab, and voclosporin offer new options for SLE and lupus nephritis.
AI-Assisted Colonoscopy: How Computer-Aided Detection

AI-assisted colonoscopy systems boost adenoma detection rates by over 40% in meta-analyses. FDA-cleared CADe tools like GI Genius reduce missed polyps in real
Pancreatic Cancer Early Detection

Pancreatic cancer has only 12% five-year survival due to late detection. Liquid biopsy, AI-enhanced imaging, and high-risk surveillance aim to improve outcomes.
Endometriosis Diagnosis: Closing the 7-Year Gap

Endometriosis affects 190 million women globally with an average 7-year diagnostic delay. New biomarkers, imaging, and targeted therapies are transforming care.
Chronic Kidney Disease Screening

CKD affects 850 million people globally yet remains underdiagnosed. KDIGO guidelines and SGLT2 inhibitors like dapagliflozin offer new strategies for detection.
Drug-Resistant Tuberculosis: New Regimens Offer Hope

Drug-resistant TB remains a global crisis killing 1.25 million annually. The BPaL regimen shows 89% success in XDR-TB, transforming the hardest-to-treat cases.
GLP-1 Medications for Adolescent Obesity

FDA-approved GLP-1 medications like Wegovy show major weight loss in adolescents. STEP TEENS trial reports 16.1% BMI reduction vs 0.6% increase with placebo.
Self-Collected HPV Testing Now Accepted

Updated guidelines now accept self-collected HPV testing for cervical cancer screening. Learn how self-collection works, who should get screened, accuracy
Liquid Biopsy for Cancer Monitoring

Circulating tumor DNA liquid biopsy detects cancer recurrence months before imaging. Used in colorectal and breast cancer to guide adjuvant therapy decisions.
Dementia Prevention: 14 Modifiable Risk Factors

The 2024 Lancet Commission identifies 14 modifiable risk factors for 45% of dementia cases. New additions: untreated vision loss and high LDL cholesterol.
Stroke Thrombectomy Extended to 24 Hours

Mechanical thrombectomy for ischemic stroke is now effective up to 24 hours after onset. DAWN and DEFUSE 3 trials dramatically improved outcomes. Time is brain.
Sleep Deprivation and Chronic Disease

The AHA added sleep to Life's Essential 8 for cardiovascular health. Short sleep raises all-cause mortality by 12% and diabetes risk significantly.
Ultra-Processed Foods Linked to Premature Death

Major research links ultra-processed foods to significantly higher mortality and chronic disease risk. Reviewed by iMedic's medical editorial team.
Extreme Heat and Health: Recognizing Heat Illness

US heat-related deaths reached record levels in 2023 according to the CDC. Learn to recognize heat exhaustion vs heat stroke and essential prevention
SGLT2 Inhibitors for Heart Failure

SGLT2 inhibitors dapagliflozin and empagliflozin reduce heart failure hospitalization by 26%. Now guideline-directed therapy for HFrEF regardless of diabetes.
Preventing Type 2 Diabetes: How Lifestyle Changes Cut

The Diabetes Prevention Program proved lifestyle intervention reduces type 2 diabetes risk by 58%. Learn about 150 min/week exercise and weight loss goals.
MRI-First Prostate Cancer Screening

MRI-first prostate cancer screening detects clinically significant tumors better than PSA alone and reduces unnecessary biopsies by 28% using PI-RADS.
PFAS in Drinking Water: Health Risks

The EPA finalized PFAS rules setting 4 ppt limits for PFOA and PFOS in drinking water. Learn about health risks, contamination, and filtration options.
Youth Vaping Crisis: E-Cigarette Health Risks

With 2.5 million US teens vaping per 2024 NYTS data, health authorities intensify action against youth e-cigarette use amid growing evidence of lung damage.
Telehealth for Chronic Disease

Telehealth utilization has grown substantially among US adults, showing significant benefits for diabetes management, hypertension control, and mental health
Gut-Brain Axis: How Your Microbiome Influences Mental

Research reveals the gut microbiome's profound influence on mental health through the gut-brain axis, with 95% of serotonin produced in the intestinal tract.
Maternal Mortality Crisis: 287,000 Annual Deaths

Global maternal mortality claims 287,000 lives annually, with hemorrhage as the leading cause. The US rate of 22.3 per 100,000 is triple that for Black women.
Long-Acting PrEP With Lenacapavir

Lenacapavir, a first-in-class capsid inhibitor given twice yearly, demonstrated unprecedented efficacy in PURPOSE trials and may overcome the adherence gap
Multi-Cancer Blood Test Screening

Exploring how multi-cancer early detection blood tests like Galleri are reshaping cancer screening paradigms, the clinical evidence behind cfDNA-based
Early-Onset Colorectal Cancer

Colorectal cancer incidence rises 2% annually in adults under 50, prompting the ACS to lower screening recommendations to age 45 and intensify research.
Universal Flu Vaccine: mRNA Approaches Advance

Universal influenza vaccine candidates using mRNA technology enter advanced clinical trials, aiming to protect against all flu subtypes and end annual shots.
Lancet Countdown 2025: Climate Change Drives Record

The Lancet Countdown report reveals record heat-related mortality, expanding vector-borne diseases, and worsening air pollution from climate change.
Mpox Clade Ib Outbreak: WHO Emergency Declaration

Mpox clade Ib spreads from DRC to neighboring countries, prompting WHO PHEIC declaration. Jynneos vaccine deployment and transmission reviewed.
GLP-1 Drug Cardiovascular Benefits

SELECT trial shows semaglutide reduces cardiovascular events by 20% in obesity. GLP-1 drugs show benefits for kidneys, heart failure, and liver disease (MASH).
AI in Medical Diagnosis: FDA-Cleared Devices

Over 900 FDA-cleared AI medical devices transform radiology and diagnostics. Deep learning accuracy, validation, and bias concerns reviewed.
Long COVID Research Update: Causes, Treatments

Long COVID affects 6-7% of infected adults. Latest research on viral persistence, immune dysregulation, microclots, and NIH RECOVER trial treatment results.
Antibiotic Resistance Crisis: WHO Global AMR Report

WHO reports 4.95 million deaths annually linked to antimicrobial resistance. ESKAPE pathogens, stewardship programs, and new antibiotics reviewed.
RSV Vaccines for Older Adults

Updated CDC guidance on RSV vaccines Arexvy and Abrysvo for adults 60+. Second season recommendations, nirsevimab for infants, and efficacy data.
H5N1 Bird Flu in US Dairy Herds: CDC Surveillance Update

CDC enhances H5N1 bird flu surveillance after HPAI detections in US dairy herds and poultry workers. Pandemic preparedness steps and current risk assessment.

Health News

Articles

GLP-1 Weight-Loss Drugs and Heart Risk

Azithromycin Fails to Improve Preschool Wheezing

Tirzepatide for Sleep Apnea: Which Patients See

How GLP-1 Drugs Like Ozempic Are Reshaping Sleep Apnea

GLP-1 Drugs Like Ozempic Open New Treatment Path

Exercise Builds Strength In The Brain First, Not Just

Tiny Gut Particles May Drive Aging and Chronic Disease

Mitochondrial Dysfunction and Memory Loss

Menopause Hot Flashes Disrupt Sleep

Which Diet Patterns May Slow Biological Aging?

How Sleep Patterns Influence Dementia Risk

Tiny Gut Particles Identified as Hidden Drivers

Weight Loss Maintenance: Randomized Trial Tests

GLP-1 Weight-Loss Drugs Linked to Lower Death

APOE2 Gene Variant Helps Neurons Repair DNA

Gut-Derived Particles May Drive Inflammaging

WHO Moves to Expand Global Access to Fast-Acting Insulin

Sleep Sweet Spot: 6.4 to 7.8 Hours Linked

Tai Chi and Baduanjin: How an 800-Year-Old Chinese

Recharging Brain Mitochondria Reverses Memory Loss

Prenatal Antidepressant Exposure and Autism/ADHD Risk

Ancient Chinese Qigong Exercise Matches Brisk Walking

Tai Chi May Lower Blood Pressure

Gut-Brain Axis: How Dysbiosis Links

Daily Coffee Linked to Lower Dementia Risk

Just 30 Minutes of Weekly High-Intensity Exercise Linked

Antidepressants in Pregnancy

Popular Workout Supplement May Reduce Heart Benefits

Optimal Sleep Duration for Healthy Aging

Healthier Plant-Based Diet Linked to Lower Dementia Risk

Resetting Aged Blood Stem Cells

Yo-Yo Dieting Reconsidered: New Analysis Challenges

Healthful Plant-Based Diet Linked to Lower Dementia

Ancient Chinese Exercise Baduanjin Lowers Blood Pressure

Daily Coffee Linked to Lower Dementia Risk

Sleep Duration Linked to Slower Biological Aging

Integrated Behavioral Health Cuts Costs

Walking Tops Americans' Favorite Exercise List

India's CDSCO Seeks Public Input on Drug Approval

Peppermint Oil Lowers Blood Pressure

Blood Pressure Drug Shows Promise for Reducing Arterial

Too Little or Too Much Sleep Accelerates Biological

Resmetirom for MASH: How the First Approved Fatty Liver

Blood Test Combining Biological Age and Genetic Risk

EMA Leverages Real-World Data Networks

FDA Blocks Publication of Studies Confirming COVID

Scientists Reverse Blood Stem Cell Aging

Prenatal Chemical Exposure at Work Linked

GLP-1 Drugs and Muscle Loss: New Research Finds Effects

8,500 Steps a Day Helps Dieters Keep Weight Off

Human Pancreatic Islet Atlas Links Cell Composition

Acupuncture and Microglial Modulation

Circadian Rhythm Sleep Disorders

Personalized mRNA Vaccine Shows Promise

Progeria: Rare Rapid-Aging Disease in Children Moves

Digitalis Glycosides Reduce Heart Failure Events

Largest Childhood Arthritis Study Uncovers

Timely Pain Treatment Cuts Hospitalizations

Healthy Aging Reframed as Public Health Priority

RNA Therapy Shows Promise Slowing Harmful Heart

First Human Bird Flu Vaccine Enters US Clinical Trials

Pancreatic Cancer Treatment Advance

Insulin-Requiring Diabetes Linked to Sharply Higher

Walking 8,500 Steps Daily May Prevent Weight Regain

Ancient Tai Chi Practice Matches Brisk Walking

Sleep Problems in Autistic Adults

Oral Orforglipron Cuts Weight and Blood Sugar

FDA Moves to Fast-Track Psilocybin and Methylone Review

FDA Delays Subcutaneous Leqembi Starting Dose Decision

Low-Dose Digoxin Shows Renewed Promise in Heart Failure

Vitamin D Overdose: When Supplements Cross

Personal Workout Music Can Extend Exercise Endurance

Naked Mole Rat Longevity Gene Transferred

Mayo Clinic Unveils New Treatment Pathways

Erectile Dysfunction After Substance Use

mRNA Cancer Vaccines: Promise of Personalized Treatment

Tenecteplase Before Thrombectomy Extends Stroke

Exercise Snacks: Short Activity Bursts Boost Fitness